103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB4637

 

Introduced 1/31/2024, by Rep. Fred Crespo

 

SYNOPSIS AS INTRODUCED:
 
225 ILCS 95/4  from Ch. 111, par. 4604
225 ILCS 95/6  from Ch. 111, par. 4606
225 ILCS 95/7  from Ch. 111, par. 4607
225 ILCS 95/7.5
225 ILCS 95/7.7
225 ILCS 95/7.8 new
225 ILCS 95/7.9 new
225 ILCS 95/17  from Ch. 111, par. 4617
225 ILCS 95/20  from Ch. 111, par. 4620
225 ILCS 95/21  from Ch. 111, par. 4621
720 ILCS 570/102  from Ch. 56 1/2, par. 1102
720 ILCS 570/303.05

    Amends the Physician Assistant Practice Act of 1987. Provides that a physician assistant may prescribe, dispense, order, administer, and procure drugs and medical devices without delegation of authority by a physician. Provides that a physician assistant may practice without a written collaborative agreement. Provides that a physician assistant who files with the Department of Financial and Professional Regulation a notarized attestation of completion of at least 250 hours of continuing education or training and at least 2,000 hours of clinical experience after first attaining national certification shall not require a written collaborative agreement. Makes changes in provisions concerning definitions; physician assistant title; collaboration requirements; written collaborative agreements, prescriptive authority, and physician assistants in hospitals, hospital affiliates, or ambulatory surgical treatment centers; inactive status; limitations; and grounds for disciplinary action. Amends the Illinois Controlled Substances Act to make corresponding changes.


LRB103 35424 SPS 65490 b

 

 

A BILL FOR

 

HB4637LRB103 35424 SPS 65490 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Physician Assistant Practice Act of 1987 is
5amended by changing Sections 4, 6, 7, 7.5, 7.7, 17, 20, and 21
6and by adding Sections 7.8 and 7.9 as follows:
 
7    (225 ILCS 95/4)  (from Ch. 111, par. 4604)
8    (Text of Section before amendment by P.A. 103-65)
9    (Section scheduled to be repealed on January 1, 2028)
10    Sec. 4. Definitions. In this Act:
11    1. "Department" means the Department of Financial and
12Professional Regulation.
13    2. "Secretary" means the Secretary of Financial and
14Professional Regulation.
15    3. "Physician assistant" means any person not holding an
16active license or permit issued by the Department pursuant to
17the Medical Practice Act of 1987 who has been certified as a
18physician assistant by the National Commission on the
19Certification of Physician Assistants or equivalent successor
20agency and performs procedures in collaboration with a
21physician as defined in this Act. A physician assistant may
22perform such procedures within the specialty of the
23collaborating physician, except that such physician shall

 

 

HB4637- 2 -LRB103 35424 SPS 65490 b

1exercise such direction, collaboration, and control over such
2physician assistants as will assure that patients shall
3receive quality medical care. Physician assistants shall be
4capable of performing a variety of tasks within the specialty
5of medical care in collaboration with a physician.
6Collaboration with the physician assistant shall not be
7construed to necessarily require the personal presence of the
8collaborating physician at all times at the place where
9services are rendered, as long as there is communication
10available for consultation by radio, telephone or
11telecommunications within established guidelines as determined
12by the physician/physician assistant team. The collaborating
13physician may delegate tasks and duties to the physician
14assistant. Delegated tasks or duties shall be consistent with
15physician assistant education, training, and experience. The
16delegated tasks or duties shall be specific to the practice
17setting and shall be implemented and reviewed under a written
18collaborative agreement established by the physician or
19physician/physician assistant team. A physician assistant,
20acting as an agent of the physician, shall be permitted to
21transmit the collaborating physician's orders as determined by
22the institution's bylaws by-laws, policies, procedures, or job
23description within which the physician/physician assistant
24team practices. Physician assistants shall practice only in
25accordance with a written collaborative agreement.
26    Any person who holds an active license or permit issued

 

 

HB4637- 3 -LRB103 35424 SPS 65490 b

1pursuant to the Medical Practice Act of 1987 shall have that
2license automatically placed into inactive status upon
3issuance of a physician assistant license. Any person who
4holds an active license as a physician assistant who is issued
5a license or permit pursuant to the Medical Practice Act of
61987 shall have his or her physician assistant license
7automatically placed into inactive status.
8    3.5. "Physician assistant practice" means the performance
9of procedures within the specialty of the collaborating
10physician. Physician assistants shall be capable of performing
11a variety of tasks within the specialty of medical care of the
12collaborating physician. Collaboration with the physician
13assistant shall not be construed to necessarily require the
14personal presence of the collaborating physician at all times
15at the place where services are rendered, as long as there is
16communication available for consultation by radio, telephone,
17telecommunications, or electronic communications. The
18collaborating physician may delegate tasks and duties to the
19physician assistant. Delegated tasks or duties shall be
20consistent with physician assistant education, training, and
21experience. The delegated tasks or duties shall be specific to
22the practice setting and shall be implemented and reviewed
23under a written collaborative agreement established by the
24physician or physician/physician assistant team. A physician
25assistant shall be permitted to transmit the collaborating
26physician's orders as determined by the institution's bylaws,

 

 

HB4637- 4 -LRB103 35424 SPS 65490 b

1policies, or procedures or the job description within which
2the physician/physician assistant team practices. Physician
3assistants shall practice only in accordance with a written
4collaborative agreement, except as provided in Section 7.5 of
5this Act.
6    4. "Board" means the Medical Licensing Board constituted
7under the Medical Practice Act of 1987.
8    5. (Blank).
9    6. "Physician" means a person licensed to practice
10medicine in all of its branches under the Medical Practice Act
11of 1987.
12    7. "Collaborating physician" means the physician who,
13within his or her specialty and expertise, may delegate a
14variety of tasks and procedures to the physician assistant.
15Such tasks and procedures shall be delegated in accordance
16with a written collaborative agreement.
17    8. (Blank).
18    9. "Address of record" means the designated address
19recorded by the Department in the applicant's or licensee's
20application file or license file maintained by the
21Department's licensure maintenance unit.
22    10. "Hospital affiliate" means a corporation, partnership,
23joint venture, limited liability company, or similar
24organization, other than a hospital, that is devoted primarily
25to the provision, management, or support of health care
26services and that directly or indirectly controls, is

 

 

HB4637- 5 -LRB103 35424 SPS 65490 b

1controlled by, or is under common control of the hospital. For
2the purposes of this definition, "control" means having at
3least an equal or a majority ownership or membership interest.
4A hospital affiliate shall be 100% owned or controlled by any
5combination of hospitals, their parent corporations, or
6physicians licensed to practice medicine in all its branches
7in Illinois. "Hospital affiliate" does not include a health
8maintenance organization regulated under the Health
9Maintenance Organization Act.
10    11. "Email address of record" means the designated email
11address recorded by the Department in the applicant's
12application file or the licensee's license file, as maintained
13by the Department's licensure maintenance unit.
14(Source: P.A. 102-1117, eff. 1-13-23.)
 
15    (Text of Section after amendment by P.A. 103-65)
16    (Section scheduled to be repealed on January 1, 2028)
17    Sec. 4. Definitions. In this Act:
18    1. "Department" means the Department of Financial and
19Professional Regulation.
20    2. "Secretary" means the Secretary of Financial and
21Professional Regulation.
22    3. "Physician assistant" means any person not holding an
23active license or permit issued by the Department pursuant to
24the Medical Practice Act of 1987 who has been certified as a
25physician assistant by the National Commission on the

 

 

HB4637- 6 -LRB103 35424 SPS 65490 b

1Certification of Physician Assistants or equivalent successor
2agency. and performs procedures in collaboration with a
3physician as defined in this Act. A physician assistant may
4perform such procedures within the specialty of the
5collaborating physician, except that such physician shall
6exercise such direction, collaboration, and control over such
7physician assistants as will assure that patients shall
8receive quality medical care. Physician assistants shall be
9capable of performing a variety of tasks within the specialty
10of medical care in collaboration with a physician.
11Collaboration with the physician assistant shall not be
12construed to necessarily require the personal presence of the
13collaborating physician at all times at the place where
14services are rendered, as long as there is communication
15available for consultation by radio, telephone or
16telecommunications within established guidelines as determined
17by the physician/physician assistant team. The collaborating
18physician may delegate tasks and duties to the physician
19assistant. Delegated tasks or duties shall be consistent with
20physician assistant education, training, and experience. The
21delegated tasks or duties shall be specific to the practice
22setting and shall be implemented and reviewed under a written
23collaborative agreement established by the physician or
24physician/physician assistant team. A physician assistant,
25acting as an agent of the physician, shall be permitted to
26transmit the collaborating physician's orders as determined by

 

 

HB4637- 7 -LRB103 35424 SPS 65490 b

1the institution's by-laws, policies, procedures, or job
2description within which the physician/physician assistant
3team practices. Physician assistants shall practice only in
4accordance with a written collaborative agreement.
5    Any person who holds an active license or permit issued
6pursuant to the Medical Practice Act of 1987 shall have that
7license automatically placed into inactive status upon
8issuance of a physician assistant license. Any person who
9holds an active license as a physician assistant who is issued
10a license or permit pursuant to the Medical Practice Act of
111987 shall have his or her physician assistant license
12automatically placed into inactive status.
13    3.5. "Physician assistant practice" means the performance
14of any legal medical service for which the physician assistant
15has been prepared by the physician assistant's education,
16training, and experience and is competent to perform as
17determined by the practice through employment agreement or
18credentialing and privileging system of the licensed facility.
19Medical and surgical services provided by physician assistants
20include, but are not limited to:
21        (A) obtaining and performing comprehensive health
22    histories and physical examinations;
23        (B) evaluating, diagnosing, managing, and providing
24    medical treatment;
25        (C) ordering, performing, and interpreting diagnostic
26    studies and therapeutic procedures;

 

 

HB4637- 8 -LRB103 35424 SPS 65490 b

1        (D) educating patients on health promotion and disease
2    prevention;
3        (E) providing consultation upon request;
4        (F) writing medical orders;
5        (G) prescribing, dispensing, ordering, administering,
6    and procuring drugs and medical devices; and
7        (H) assisting in surgery. procedures within the
8    specialty of the collaborating physician. Physician
9    assistants shall be capable of performing a variety of
10    tasks within the specialty of medical care of the
11    collaborating physician. Collaboration with the physician
12    assistant shall not be construed to necessarily require
13    the personal presence of the collaborating physician at
14    all times at the place where services are rendered, as
15    long as there is communication available for consultation
16    by radio, telephone, telecommunications, or electronic
17    communications. The collaborating physician may delegate
18    tasks and duties to the physician assistant. Delegated
19    tasks or duties shall be consistent with physician
20    assistant education, training, and experience. The
21    delegated tasks or duties shall be specific to the
22    practice setting and shall be implemented and reviewed
23    under a written collaborative agreement established by the
24    physician or physician/physician assistant team. A
25    physician assistant shall be permitted to transmit the
26    collaborating physician's orders as determined by the

 

 

HB4637- 9 -LRB103 35424 SPS 65490 b

1    institution's bylaws, policies, or procedures or the job
2    description within which the physician/physician assistant
3    team practices. Physician assistants shall practice only
4    in accordance with a written collaborative agreement,
5    except as provided in Section 7.5 of this Act.
6    4. "Board" means the Illinois State Medical Board Medical
7Licensing Board constituted under the Medical Practice Act of
81987.
9    5. (Blank).
10    6. "Physician" means a person licensed to practice
11medicine in all of its branches under the Medical Practice Act
12of 1987.
13    7. "Collaborating physician" means the physician who,
14within his or her specialty and expertise, may delegate a
15variety of tasks and procedures to the physician assistant.
16Such tasks and procedures shall be delegated in accordance
17with a written collaborative agreement when the agreement is
18required under this Act.
19    8. (Blank).
20    9. "Address of record" means the designated address
21recorded by the Department in the applicant's or licensee's
22application file or license file maintained by the
23Department's licensure maintenance unit.
24    10. "Hospital affiliate" means a corporation, partnership,
25joint venture, limited liability company, or similar
26organization, other than a hospital, that is devoted primarily

 

 

HB4637- 10 -LRB103 35424 SPS 65490 b

1to the provision, management, or support of health care
2services and that directly or indirectly controls, is
3controlled by, or is under common control of the hospital. For
4the purposes of this definition, "control" means having at
5least an equal or a majority ownership or membership interest.
6A hospital affiliate shall be 100% owned or controlled by any
7combination of hospitals, their parent corporations, or
8physicians licensed to practice medicine in all its branches
9in Illinois. "Hospital affiliate" does not include a health
10maintenance organization regulated under the Health
11Maintenance Organization Act.
12    11. "Email address of record" means the designated email
13address recorded by the Department in the applicant's
14application file or the licensee's license file, as maintained
15by the Department's licensure maintenance unit.
16    12. "Federally qualified health center" means a health
17center funded under Section 330 of the federal Public Health
18Service Act.
19(Source: P.A. 102-1117, eff. 1-13-23; 103-65, eff. 1-1-24.)
 
20    (225 ILCS 95/6)  (from Ch. 111, par. 4606)
21    (Section scheduled to be repealed on January 1, 2028)
22    Sec. 6. Physician assistant title.
23    (a) No physician assistant shall use the title of doctor,
24physician, or associate with his or her name or any other term
25that would indicate to other persons that he or she is

 

 

HB4637- 11 -LRB103 35424 SPS 65490 b

1qualified to engage in the general practice of medicine.
2    (b) A physician assistant shall verbally identify himself
3or herself as a physician assistant, including, when
4applicable, specialty certification, to each patient.
5    (c) Nothing in this Act shall be construed to relieve a
6physician assistant of the professional or legal
7responsibility for the care and treatment of persons attended
8by him or her.
9    (d) (Blank). The collaborating physician shall file with
10the Department notice of employment, discharge, or
11collaboration with a physician assistant within 60 days of
12employment, discharge, or assumption of collaboration with a
13physician assistant. Nothing in this Section shall prevent a
14physician assistant from beginning his or her employment
15before the notice of employment or collaboration has been
16filed.
17(Source: P.A. 102-735, eff. 1-1-23.)
 
18    (225 ILCS 95/7)  (from Ch. 111, par. 4607)
19    (Text of Section before amendment by P.A. 103-65)
20    (Section scheduled to be repealed on January 1, 2028)
21    Sec. 7. Collaboration requirements.
22    (a) A collaborating physician shall determine the number
23of physician assistants to collaborate with, provided the
24physician is able to provide adequate collaboration as
25outlined in the written collaborative agreement required under

 

 

HB4637- 12 -LRB103 35424 SPS 65490 b

1Section 7.5 of this Act and consideration is given to the
2nature of the physician's practice, complexity of the patient
3population, and the experience of each physician assistant. A
4collaborating physician may collaborate with a maximum of 7
5full-time equivalent physician assistants as described in
6Section 54.5 of the Medical Practice Act of 1987. As used in
7this Section, "full-time equivalent" means the equivalent of
840 hours per week per individual. Physicians and physician
9assistants who work in a hospital, hospital affiliate, or
10ambulatory surgical treatment center as defined by Section 7.7
11of this Act are exempt from the collaborative ratio
12restriction requirements of this Section. A physician
13assistant shall be able to hold more than one professional
14position. A collaborating physician shall file a notice of
15collaboration of each physician assistant according to the
16rules of the Department.
17    Physician assistants shall collaborate only with
18physicians as defined in this Act who are engaged in clinical
19practice, or in clinical practice in public health or other
20community health facilities.
21    Nothing in this Act shall be construed to limit the
22delegation of tasks or duties by a physician to a nurse or
23other appropriately trained personnel.
24    Nothing in this Act shall be construed to prohibit the
25employment of physician assistants by a hospital, nursing home
26or other health care facility where such physician assistants

 

 

HB4637- 13 -LRB103 35424 SPS 65490 b

1function with under a collaborating physician.
2    A physician assistant may be employed by a practice group
3or other entity employing multiple physicians at one or more
4locations. In that case, one of the physicians practicing at a
5location shall be designated the collaborating physician. The
6other physicians with that practice group or other entity who
7practice in the same general type of practice or specialty as
8the collaborating physician may collaborate with the physician
9assistant with respect to their patients.
10    (b) A physician assistant licensed in this State, or
11licensed or authorized to practice in any other U.S.
12jurisdiction or credentialed by his or her federal employer as
13a physician assistant, who is responding to a need for medical
14care created by an emergency or by a state or local disaster
15may render such care that the physician assistant is able to
16provide without collaboration as it is defined in this Section
17or with such collaboration as is available.
18    Any physician who collaborates with a physician assistant
19providing medical care in response to such an emergency or
20state or local disaster shall not be required to meet the
21requirements set forth in this Section for a collaborating
22physician.
23(Source: P.A. 100-453, eff. 8-25-17; 100-605, eff. 1-1-19.)
 
24    (Text of Section after amendment by P.A. 103-65)
25    (Section scheduled to be repealed on January 1, 2028)

 

 

HB4637- 14 -LRB103 35424 SPS 65490 b

1    Sec. 7. Collaboration requirements.
2    (a) A written collaborative agreement is required for all
3physician assistants engaged in clinical practice prior to
4satisfying the requirements of Section 7.9, except for
5physician assistants who practice in a hospital, hospital
6affiliate, federally qualified health center, or ambulatory
7surgical treatment center as provided in Section 7.7.
8    (b) (a) A collaborating physician shall determine the
9number of physician assistants to collaborate with, provided
10the physician is able to provide adequate collaboration as
11outlined in the written collaborative agreement required under
12Section 7.5 of this Act and consideration is given to the
13nature of the physician's practice, complexity of the patient
14population, and the experience of each physician assistant. A
15collaborating physician may collaborate with a maximum of 7
16full-time equivalent physician assistants as described in
17Section 54.5 of the Medical Practice Act of 1987. As used in
18this Section, "full-time equivalent" means the equivalent of
1940 hours per week per individual. Physicians and physician
20assistants who work in a hospital, hospital affiliate,
21federally qualified health center, or ambulatory surgical
22treatment center as defined by Section 7.7 of this Act are
23exempt from the collaborative ratio restriction requirements
24of this Section. A physician assistant shall be able to hold
25more than one professional position. A collaborating physician
26shall file a notice of collaboration of each physician

 

 

HB4637- 15 -LRB103 35424 SPS 65490 b

1assistant according to the rules of the Department.
2    (c) Physician assistants shall collaborate only with
3physicians as defined in this Act who are engaged in clinical
4practice, or in clinical practice in public health or other
5community health facilities.
6    (d) Nothing in this Act shall be construed to limit the
7delegation of tasks or duties by a physician to a nurse or
8other appropriately trained personnel.
9    (e) Nothing in this Act shall be construed to prohibit the
10employment of physician assistants by a hospital, nursing home
11or other health care facility where such physician assistants
12function with under a collaborating physician.
13    (f) A physician assistant may be employed by a practice
14group or other entity employing multiple physicians at one or
15more locations. In that case, one of the physicians practicing
16at a location shall be designated the collaborating physician.
17The other physicians with that practice group or other entity
18who practice in the same general type of practice or specialty
19as the collaborating physician may collaborate with the
20physician assistant with respect to their patients.
21    (g) (b) A physician assistant licensed in this State, or
22licensed or authorized to practice in any other U.S.
23jurisdiction or credentialed by his or her federal employer as
24a physician assistant, who is responding to a need for medical
25care created by an emergency or by a state or local disaster
26may render such care that the physician assistant is able to

 

 

HB4637- 16 -LRB103 35424 SPS 65490 b

1provide without collaboration as it is defined in this Section
2or with such collaboration as is available.
3    (h) Any physician who collaborates with a physician
4assistant providing medical care in response to such an
5emergency or state or local disaster shall not be required to
6meet the requirements set forth in this Section for a
7collaborating physician.
8(Source: P.A. 103-65, eff. 1-1-24.)
 
9    (225 ILCS 95/7.5)
10    (Text of Section before amendment by P.A. 103-65)
11    (Section scheduled to be repealed on January 1, 2028)
12    Sec. 7.5. Written collaborative agreements; prescriptive
13authority.
14    (a) A written collaborative agreement is required for all
15physician assistants to practice in the State, except as
16provided in Section 7.7 of this Act.
17        (1) A written collaborative agreement shall describe
18    the working relationship of the physician assistant with
19    the collaborating physician and shall describe the
20    categories of care, treatment, or procedures to be
21    provided by the physician assistant. The written
22    collaborative agreement shall promote the exercise of
23    professional judgment by the physician assistant
24    commensurate with his or her education and experience. The
25    services to be provided by the physician assistant shall

 

 

HB4637- 17 -LRB103 35424 SPS 65490 b

1    be services that the collaborating physician is authorized
2    to and generally provides to his or her patients in the
3    normal course of his or her clinical medical practice. The
4    written collaborative agreement need not describe the
5    exact steps that a physician assistant must take with
6    respect to each specific condition, disease, or symptom
7    but must specify which authorized procedures require the
8    presence of the collaborating physician as the procedures
9    are being performed. The relationship under a written
10    collaborative agreement shall not be construed to require
11    the personal presence of a physician at the place where
12    services are rendered. Methods of communication shall be
13    available for consultation with the collaborating
14    physician in person or by telecommunications or electronic
15    communications as set forth in the written collaborative
16    agreement. For the purposes of this Act, "generally
17    provides to his or her patients in the normal course of his
18    or her clinical medical practice" means services, not
19    specific tasks or duties, the collaborating physician
20    routinely provides individually or through delegation to
21    other persons so that the physician has the experience and
22    ability to collaborate and provide consultation.
23        (2) The written collaborative agreement shall be
24    adequate if a physician does each of the following:
25            (A) Participates in the joint formulation and
26        joint approval of orders or guidelines with the

 

 

HB4637- 18 -LRB103 35424 SPS 65490 b

1        physician assistant and he or she periodically reviews
2        such orders and the services provided patients under
3        such orders in accordance with accepted standards of
4        medical practice and physician assistant practice.
5            (B) Provides consultation at least once a month.
6        (3) A copy of the signed, written collaborative
7    agreement must be available to the Department upon request
8    from both the physician assistant and the collaborating
9    physician.
10        (4) A physician assistant shall inform each
11    collaborating physician of all written collaborative
12    agreements he or she has signed and provide a copy of these
13    to any collaborating physician upon request.
14    (b) A collaborating physician may, but is not required to,
15delegate prescriptive authority to a physician assistant as
16part of a written collaborative agreement. This authority may,
17but is not required to, include prescription of, selection of,
18orders for, administration of, storage of, acceptance of
19samples of, and dispensing medical devices, over-the-counter
20over the counter medications, legend drugs, medical gases, and
21controlled substances categorized as Schedule II through V
22controlled substances, as defined in Article II of the
23Illinois Controlled Substances Act, and other preparations,
24including, but not limited to, botanical and herbal remedies.
25The collaborating physician must have a valid, current
26Illinois controlled substance license and federal registration

 

 

HB4637- 19 -LRB103 35424 SPS 65490 b

1with the Drug Enforcement Administration to delegate the
2authority to prescribe controlled substances.
3        (1) To prescribe Schedule II, III, IV, or V controlled
4    substances under this Section, a physician assistant must
5    obtain a mid-level practitioner controlled substances
6    license. Medication orders issued by a physician assistant
7    shall be reviewed periodically by the collaborating
8    physician.
9        (2) The collaborating physician shall file with the
10    Department notice of delegation of prescriptive authority
11    to a physician assistant and termination of delegation,
12    specifying the authority delegated or terminated. Upon
13    receipt of this notice delegating authority to prescribe
14    controlled substances, the physician assistant shall be
15    eligible to register for a mid-level practitioner
16    controlled substances license under Section 303.05 of the
17    Illinois Controlled Substances Act. Nothing in this Act
18    shall be construed to limit the delegation of tasks or
19    duties by the collaborating physician to a nurse or other
20    appropriately trained persons in accordance with Section
21    54.2 of the Medical Practice Act of 1987.
22        (3) In addition to the requirements of this subsection
23    (b), a collaborating physician may, but is not required
24    to, delegate authority to a physician assistant to
25    prescribe Schedule II controlled substances, if all of the
26    following conditions apply:

 

 

HB4637- 20 -LRB103 35424 SPS 65490 b

1            (A) Specific Schedule II controlled substances by
2        oral dosage or topical or transdermal application may
3        be delegated, provided that the delegated Schedule II
4        controlled substances are routinely prescribed by the
5        collaborating physician. This delegation must identify
6        the specific Schedule II controlled substances by
7        either brand name or generic name. Schedule II
8        controlled substances to be delivered by injection or
9        other route of administration may not be delegated.
10            (B) (Blank).
11            (C) Any prescription must be limited to no more
12        than a 30-day supply, with any continuation authorized
13        only after prior approval of the collaborating
14        physician.
15            (D) The physician assistant must discuss the
16        condition of any patients for whom a controlled
17        substance is prescribed monthly with the collaborating
18        physician.
19            (E) The physician assistant meets the education
20        requirements of Section 303.05 of the Illinois
21        Controlled Substances Act.
22    (c) Nothing in this Act shall be construed to limit the
23delegation of tasks or duties by a physician to a licensed
24practical nurse, a registered professional nurse, or other
25persons. Nothing in this Act shall be construed to limit the
26method of delegation that may be authorized by any means,

 

 

HB4637- 21 -LRB103 35424 SPS 65490 b

1including, but not limited to, oral, written, electronic,
2standing orders, protocols, guidelines, or verbal orders.
3Nothing in this Act shall be construed to authorize a
4physician assistant to provide health care services required
5by law or rule to be performed by a physician. Nothing in this
6Act shall be construed to authorize the delegation or
7performance of operative surgery. Nothing in this Section
8shall be construed to preclude a physician assistant from
9assisting in surgery.
10    (c-5) Nothing in this Section shall be construed to apply
11to any medication authority, including Schedule II controlled
12substances of a licensed physician assistant for care provided
13in a hospital, hospital affiliate, or ambulatory surgical
14treatment center pursuant to Section 7.7 of this Act.
15    (d) (Blank).
16    (e) Nothing in this Section shall be construed to prohibit
17generic substitution.
18(Source: P.A. 101-13, eff. 6-12-19; 102-558, eff. 8-20-21;
19revised 9-21-23.)
 
20    (Text of Section after amendment by P.A. 103-65)
21    (Section scheduled to be repealed on January 1, 2028)
22    Sec. 7.5. Written collaborative agreements; prescriptive
23authority.
24    (a) A written collaborative agreement is required for all
25physician assistants to practice in the State, except as

 

 

HB4637- 22 -LRB103 35424 SPS 65490 b

1provided in Sections Section 7.7 and 7.9 of this Act. When a
2written collaborative agreement is required under this Act,
3the following shall apply:
4        (1) A written collaborative agreement shall describe
5    the working relationship of the physician assistant with
6    the collaborating physician and shall describe the
7    categories of care, treatment, or procedures to be
8    provided by the physician assistant. The written
9    collaborative agreement shall promote the exercise of
10    professional judgment by the physician assistant
11    commensurate with his or her education and experience. The
12    services to be provided by the physician assistant shall
13    be services that the collaborating physician is authorized
14    to and generally provides to his or her patients in the
15    normal course of his or her clinical medical practice. The
16    written collaborative agreement need not describe the
17    exact steps that a physician assistant must take with
18    respect to each specific condition, disease, or symptom
19    but must specify which authorized procedures require the
20    presence of the collaborating physician as the procedures
21    are being performed. The relationship under a written
22    collaborative agreement shall not be construed to require
23    the personal presence of a physician at the place where
24    services are rendered. Methods of communication shall be
25    available for consultation with the collaborating
26    physician in person or by telecommunications or electronic

 

 

HB4637- 23 -LRB103 35424 SPS 65490 b

1    communications as set forth in the written collaborative
2    agreement. For the purposes of this Act, "generally
3    provides to his or her patients in the normal course of his
4    or her clinical medical practice" means services, not
5    specific tasks or duties, the collaborating physician
6    routinely provides individually or through delegation to
7    other persons so that the physician has the experience and
8    ability to collaborate and provide consultation.
9        (2) (Blank). The written collaborative agreement shall
10    be adequate if a physician does each of the following:
11            (A) Participates in the joint formulation and
12        joint approval of orders or guidelines with the
13        physician assistant and he or she periodically reviews
14        such orders and the services provided patients under
15        such orders in accordance with accepted standards of
16        medical practice and physician assistant practice.
17            (B) Provides consultation at least once a month.
18        (3) A copy of the signed, written collaborative
19    agreement must be available to the Department upon request
20    from both the physician assistant and the collaborating
21    physician.
22        (4) A physician assistant shall inform each
23    collaborating physician of all written collaborative
24    agreements he or she has signed and provide a copy of these
25    to any collaborating physician upon request.
26    (b) To prescribe Schedule II, III, IV, or V controlled

 

 

HB4637- 24 -LRB103 35424 SPS 65490 b

1substances under this Section, a physician assistant must
2obtain a mid-level practitioner controlled substances license.
3A collaborating physician may, but is not required to,
4delegate prescriptive authority to a physician assistant as
5part of a written collaborative agreement. This authority may,
6but is not required to, include prescription of, selection of,
7orders for, administration of, storage of, acceptance of
8samples of, and dispensing medical devices, over the counter
9medications, legend drugs, medical gases, and controlled
10substances categorized as Schedule II through V controlled
11substances, as defined in Article II of the Illinois
12Controlled Substances Act, and other preparations, including,
13but not limited to, botanical and herbal remedies. The
14collaborating physician must have a valid, current Illinois
15controlled substance license and federal registration with the
16Drug Enforcement Administration to delegate the authority to
17prescribe controlled substances.
18        (1) To prescribe Schedule II, III, IV, or V controlled
19    substances under this Section, a physician assistant must
20    obtain a mid-level practitioner controlled substances
21    license. Medication orders issued by a physician assistant
22    shall be reviewed periodically by the collaborating
23    physician.
24        (2) The collaborating physician shall file with the
25    Department notice of delegation of prescriptive authority
26    to a physician assistant and termination of delegation,

 

 

HB4637- 25 -LRB103 35424 SPS 65490 b

1    specifying the authority delegated or terminated. Upon
2    receipt of this notice delegating authority to prescribe
3    controlled substances, the physician assistant shall be
4    eligible to register for a mid-level practitioner
5    controlled substances license under Section 303.05 of the
6    Illinois Controlled Substances Act. Nothing in this Act
7    shall be construed to limit the delegation of tasks or
8    duties by the collaborating physician to a nurse or other
9    appropriately trained persons in accordance with Section
10    54.2 of the Medical Practice Act of 1987.
11        (3) In addition to the requirements of this subsection
12    (b), a collaborating physician may, but is not required
13    to, delegate authority to a physician assistant to
14    prescribe Schedule II controlled substances, if all of the
15    following conditions apply:
16            (A) Specific Schedule II controlled substances by
17        oral dosage or topical or transdermal application may
18        be delegated, provided that the delegated Schedule II
19        controlled substances are routinely prescribed by the
20        collaborating physician. This delegation must identify
21        the specific Schedule II controlled substances by
22        either brand name or generic name. Schedule II
23        controlled substances to be delivered by injection or
24        other route of administration may not be delegated.
25            (B) (Blank).
26            (C) Any prescription must be limited to no more

 

 

HB4637- 26 -LRB103 35424 SPS 65490 b

1        than a 30-day supply, with any continuation authorized
2        only after prior approval of the collaborating
3        physician.
4            (D) The physician assistant must discuss the
5        condition of any patients for whom a controlled
6        substance is prescribed monthly with the collaborating
7        physician.
8            (E) The physician assistant meets the education
9        requirements of Section 303.05 of the Illinois
10        Controlled Substances Act.
11    (c) Nothing in this Act shall be construed to limit the
12delegation of tasks or duties by a physician to a licensed
13practical nurse, a registered professional nurse, or other
14persons. Nothing in this Act shall be construed to limit the
15method of delegation that may be authorized by any means,
16including, but not limited to, oral, written, electronic,
17standing orders, protocols, guidelines, or verbal orders.
18Nothing in this Act shall be construed to authorize a
19physician assistant to provide health care services required
20by law or rule to be performed by a physician. Nothing in this
21Act shall be construed to authorize the delegation or
22performance of operative surgery. Nothing in this Section
23shall be construed to preclude a physician assistant from
24assisting in surgery.
25    (c-5) Nothing in this Section shall be construed to apply
26to any medication authority, including Schedule II controlled

 

 

HB4637- 27 -LRB103 35424 SPS 65490 b

1substances of a licensed physician assistant for care provided
2in a hospital, hospital affiliate, federally qualified health
3center, or ambulatory surgical treatment center pursuant to
4Section 7.7 of this Act, or to a physician assistant
5satisfying the requirements of Section 7.9.
6    (d) (Blank).
7    (e) Nothing in this Section shall be construed to prohibit
8generic substitution.
9    (f) Delegation of prescriptive authority by a physician is
10not required under this Section.
11(Source: P.A. 102-558, eff. 8-20-21; 103-65, eff. 1-1-24;
12revised 9-21-23.)
 
13    (225 ILCS 95/7.7)
14    (Text of Section before amendment by P.A. 103-65)
15    (Section scheduled to be repealed on January 1, 2028)
16    Sec. 7.7. Physician assistants in hospitals, hospital
17affiliates, or ambulatory surgical treatment centers.
18    (a) A physician assistant may provide services in a
19hospital as defined in the Hospital Licensing Act, a hospital
20affiliate as defined in the University of Illinois Hospital
21Act, or a licensed ambulatory surgical treatment center as
22defined in the Ambulatory Surgical Treatment Center Act
23without a written collaborative agreement pursuant to Section
247.5 of this Act. A physician assistant must possess clinical
25privileges recommended by the hospital medical staff and

 

 

HB4637- 28 -LRB103 35424 SPS 65490 b

1granted by the hospital or the consulting medical staff
2committee and ambulatory surgical treatment center in order to
3provide services. The medical staff or consulting medical
4staff committee shall periodically review the services of
5physician assistants granted clinical privileges, including
6any care provided in a hospital affiliate. Authority may also
7be granted when recommended by the hospital medical staff and
8granted by the hospital or recommended by the consulting
9medical staff committee and ambulatory surgical treatment
10center to individual physician assistants to select, order,
11and administer medications, including controlled substances,
12to provide delineated care. In a hospital, hospital affiliate,
13or ambulatory surgical treatment center, the attending
14physician shall determine a physician assistant's role in
15providing care for his or her patients, except as otherwise
16provided in the medical staff bylaws or consulting committee
17policies.
18    (a-5) Physician assistants practicing in a hospital
19affiliate may be, but are not required to be, granted
20authority to prescribe Schedule II through V controlled
21substances when such authority is recommended by the
22appropriate physician committee of the hospital affiliate and
23granted by the hospital affiliate. This authority may, but is
24not required to, include prescription of, selection of, orders
25for, administration of, storage of, acceptance of samples of,
26and dispensing over-the-counter medications, legend drugs,

 

 

HB4637- 29 -LRB103 35424 SPS 65490 b

1medical gases, and controlled substances categorized as
2Schedule II through V controlled substances, as defined in
3Article II of the Illinois Controlled Substances Act, and
4other preparations, including, but not limited to, botanical
5and herbal remedies.
6    To prescribe controlled substances under this subsection
7(a-5), a physician assistant must obtain a mid-level
8practitioner controlled substance license. Medication orders
9shall be reviewed periodically by the appropriate hospital
10affiliate physicians committee or its physician designee.
11    The hospital affiliate shall file with the Department
12notice of a grant of prescriptive authority consistent with
13this subsection (a-5) and termination of such a grant of
14authority in accordance with rules of the Department. Upon
15receipt of this notice of grant of authority to prescribe any
16Schedule II through V controlled substances, the licensed
17physician assistant may register for a mid-level practitioner
18controlled substance license under Section 303.05 of the
19Illinois Controlled Substances Act.
20    In addition, a hospital affiliate may, but is not required
21to, grant authority to a physician assistant to prescribe any
22Schedule II controlled substances if all of the following
23conditions apply:
24        (1) specific Schedule II controlled substances by oral
25    dosage or topical or transdermal application may be
26    designated, provided that the designated Schedule II

 

 

HB4637- 30 -LRB103 35424 SPS 65490 b

1    controlled substances are routinely prescribed by
2    physician assistants in their area of certification; this
3    grant of authority must identify the specific Schedule II
4    controlled substances by either brand name or generic
5    name; authority to prescribe or dispense Schedule II
6    controlled substances to be delivered by injection or
7    other route of administration may not be granted;
8        (2) any grant of authority must be controlled
9    substances limited to the practice of the physician
10    assistant;
11        (3) any prescription must be limited to no more than a
12    30-day supply;
13        (4) the physician assistant must discuss the condition
14    of any patients for whom a controlled substance is
15    prescribed monthly with the appropriate physician
16    committee of the hospital affiliate or its physician
17    designee; and
18        (5) the physician assistant must meet the education
19    requirements of Section 303.05 of the Illinois Controlled
20    Substances Act.
21    (b) A physician assistant granted authority to order
22medications including controlled substances may complete
23discharge prescriptions provided the prescription is in the
24name of the physician assistant and the attending or
25discharging physician.
26    (c) Physician assistants practicing in a hospital,

 

 

HB4637- 31 -LRB103 35424 SPS 65490 b

1hospital affiliate, or an ambulatory surgical treatment center
2are not required to obtain a mid-level controlled substance
3license to order controlled substances under Section 303.05 of
4the Illinois Controlled Substances Act.
5(Source: P.A. 100-453, eff. 8-25-17.)
 
6    (Text of Section after amendment by P.A. 103-65)
7    (Section scheduled to be repealed on January 1, 2028)
8    Sec. 7.7. Physician assistants in hospitals, hospital
9affiliates, federally qualified health centers, or ambulatory
10surgical treatment centers.
11    (a) A physician assistant may provide services in a
12hospital as defined in the Hospital Licensing Act, a hospital
13affiliate as defined in the University of Illinois Hospital
14Act, a federally qualified health center, or a licensed
15ambulatory surgical treatment center as defined in the
16Ambulatory Surgical Treatment Center Act without a written
17collaborative agreement pursuant to Section 7.5 of this Act
18only in accordance with this Section. A physician assistant
19must possess clinical privileges recommended by (i) the
20hospital medical staff and granted by the hospital, (ii) the
21physician committee and federally qualified health center, or
22(iii) the consulting medical staff committee and ambulatory
23surgical treatment center in order to provide services. The
24medical staff, physician committee, or consulting medical
25staff committee shall periodically review the services of

 

 

HB4637- 32 -LRB103 35424 SPS 65490 b

1physician assistants granted clinical privileges, including
2any care provided in a hospital affiliate or federally
3qualified health center. A physician assistant practicing
4under this Section may prescribe, select, order, and
5administer medications, including controlled substances.
6Authority may also be granted when recommended by the hospital
7medical staff and granted by the hospital, recommended by the
8physician committee and granted by the federally qualified
9health center, or recommended by the consulting medical staff
10committee and ambulatory surgical treatment center to
11individual physician assistants to select, order, and
12administer medications, including controlled substances, to
13provide delineated care. In a hospital, hospital affiliate,
14federally qualified health center, or ambulatory surgical
15treatment center, the attending physician shall determine a
16physician assistant's role in providing care for his or her
17patients, except as otherwise provided in the medical staff
18bylaws or consulting committee policies.
19    (a-5) Physician assistants practicing in a hospital
20affiliate or a federally qualified health center may be, but
21are not required to be, granted authority to prescribe
22Schedule II through V controlled substances when such
23authority is recommended by the appropriate physician
24committee of the hospital affiliate and granted by the
25hospital affiliate or recommended by the physician committee
26of the federally qualified health center and granted by the

 

 

HB4637- 33 -LRB103 35424 SPS 65490 b

1federally qualified health center. This authority may, but is
2not required to, include prescription of, selection of, orders
3for, administration of, storage of, acceptance of samples of,
4and dispensing over-the-counter medications, legend drugs,
5medical gases, and controlled substances categorized as
6Schedule II through V controlled substances, as defined in
7Article II of the Illinois Controlled Substances Act, and
8other preparations, including, but not limited to, botanical
9and herbal remedies.
10    To prescribe controlled substances under this subsection
11(a-5), a physician assistant must obtain a mid-level
12practitioner controlled substance license. Medication orders
13shall be reviewed periodically by the appropriate hospital
14affiliate physicians committee or its physician designee or by
15the physician committee of a federally qualified health
16center.
17    The hospital affiliate or federally qualified health
18center shall file with the Department notice of a grant of
19prescriptive authority consistent with this subsection (a-5)
20and termination of such a grant of authority in accordance
21with rules of the Department. Upon receipt of this notice of
22grant of authority to prescribe any Schedule II through V
23controlled substances, the licensed physician assistant may
24register for a mid-level practitioner controlled substance
25license under Section 303.05 of the Illinois Controlled
26Substances Act.

 

 

HB4637- 34 -LRB103 35424 SPS 65490 b

1    In addition, a hospital affiliate or a federally qualified
2health center may, but is not required to, grant authority to a
3physician assistant to prescribe any Schedule II controlled
4substances if all of the following conditions apply:
5        (1) specific Schedule II controlled substances by oral
6    dosage or topical or transdermal application may be
7    designated, provided that the designated Schedule II
8    controlled substances are routinely prescribed by
9    physician assistants in their area of certification; this
10    grant of authority must identify the specific Schedule II
11    controlled substances by either brand name or generic
12    name; authority to prescribe or dispense Schedule II
13    controlled substances to be delivered by injection or
14    other route of administration may not be granted;
15        (2) any grant of authority must be controlled
16    substances limited to the practice of the physician
17    assistant;
18        (3) any prescription must be limited to no more than a
19    30-day supply;
20        (4) the physician assistant must discuss the condition
21    of any patients for whom a controlled substance is
22    prescribed monthly with the appropriate physician
23    committee of the hospital affiliate or its physician
24    designee, or the physician committee of a federally
25    qualified health center; and
26        (5) the physician assistant must meet the education

 

 

HB4637- 35 -LRB103 35424 SPS 65490 b

1    requirements of Section 303.05 of the Illinois Controlled
2    Substances Act.
3    (b) A physician assistant granted authority to order
4medications including controlled substances may complete
5discharge prescriptions provided the prescription is in the
6name of the physician assistant and the attending or
7discharging physician.
8    (c) Physician assistants practicing in a hospital,
9hospital affiliate, federally qualified health center, or an
10ambulatory surgical treatment center are not required to
11obtain a mid-level controlled substance license to order
12controlled substances under Section 303.05 of the Illinois
13Controlled Substances Act.
14    (d) Delegation of prescriptive authority by a physician is
15not required under this Section.
16(Source: P.A. 103-65, eff. 1-1-24.)
 
17    (225 ILCS 95/7.8 new)
18    Sec. 7.8. Prescriptive authority. A physician assistant
19may prescribe, dispense, order, administer, and procure drugs
20and medical devices without delegation of authority by a
21physician. The prescriptive authority may include prescribing
22Schedule II, III, IV, and V controlled substances. To
23prescribe Schedule II, III, IV, or V controlled substances
24under this Act, a physician assistant must obtain a mid-level
25practitioner controlled substances license. When a written

 

 

HB4637- 36 -LRB103 35424 SPS 65490 b

1collaborative agreement is required under this Act, delegation
2of prescriptive authority by a physician is not required.
 
3    (225 ILCS 95/7.9 new)
4    Sec. 7.9. Optimal practice.
5    (a) A physician assistant may practice without a written
6collaborative agreement as described in this Section.
7    (b) A physician assistant who files with the Department a
8notarized attestation of completion of at least 250 hours of
9continuing education or training and at least 2,000 hours of
10clinical experience after first attaining national
11certification shall not require a written collaborative
12agreement. Documentation of successful completion shall be
13provided to the Department upon request.
14    (c) The scope of practice of a physician assistant with
15optimal practice includes:
16        (1) all matters defined as physician assistant
17    practice;
18        (2) practicing without a written collaborative
19    agreement in all practice settings consistent with this
20    Act;
21        (3) authority to prescribe both legend drugs and
22    Schedule II through V controlled substances, including
23    prescription of, selection of, orders for, administration
24    of, storage of, acceptance of samples of, and dispensing
25    over-the-counter medications, legend drugs, and controlled

 

 

HB4637- 37 -LRB103 35424 SPS 65490 b

1    substances categorized as any Schedule II through V
2    controlled substances, as defined in Article II of the
3    Illinois Controlled Substances Act, and other
4    preparations, including, but not limited to, botanical and
5    herbal remedies; and
6        (4) authority to obtain an Illinois controlled
7    substance license and a federal Drug Enforcement
8    Administration number.
9    The scope of practice of a physician assistant does not
10include operative surgery. Nothing in this Section shall be
11construed to preclude a physician assistant from assisting in
12surgery or performing other procedures as privileged by the
13physician assistant's employer.
14    (d) The Department may adopt rules necessary to administer
15this Section, including, but not limited to, requiring the
16completion of forms and the payment of fees.
17    (e) Nothing in this Section shall be construed to prohibit
18a physician assistant's employer from requiring a physician
19assistant who satisfies the qualifications of subsection (b)
20to practice with a written collaborative agreement.
21    (f) Nothing in this Act shall be construed to authorize a
22physician assistant with optimal practice authority to provide
23health care services required by law or rule to be performed by
24a physician.
 
25    (225 ILCS 95/17)  (from Ch. 111, par. 4617)

 

 

HB4637- 38 -LRB103 35424 SPS 65490 b

1    (Section scheduled to be repealed on January 1, 2028)
2    Sec. 17. Inactive status. Any physician assistant who
3notified the Department in writing on forms prescribed by the
4Department, may elect to place his or her license on an
5inactive status and shall, subject to rules of the Department,
6be excused from payment of renewal fees until he or she
7notifies the Department in writing of his or her intention to
8restore the license. Any person who holds an active license or
9permit issued under the Medical Practice Act of 1987 shall
10have that license or permit automatically placed into inactive
11status upon issuance of a physician assistant license. Any
12person who holds an active license as a physician assistant
13who is issued a license or permit under the Medical Practice
14Act of 1987 shall have the physician assistant license
15automatically placed into inactive status.
16    Any physician assistant requesting restoration from
17inactive status shall be required to pay the current renewal
18fee and shall be required to restore his or her license, as
19provided in Section 16 of this Act.
20    Any physician assistant whose license is in an inactive
21status shall not practice in the State of Illinois.
22    Any licensee who shall engage in practice while his or her
23license is lapsed or on inactive status shall be considered to
24be practicing without a license, which shall be grounds for
25discipline under Section 21 of this Act.
26(Source: P.A. 90-61, eff. 12-30-97.)
 

 

 

HB4637- 39 -LRB103 35424 SPS 65490 b

1    (225 ILCS 95/20)  (from Ch. 111, par. 4620)
2    (Section scheduled to be repealed on January 1, 2028)
3    Sec. 20. Limitations.
4    (a) No corporation, which stated purpose includes, or
5which practices, or which holds itself out as available to
6practice as a physician assistant or to practice any of the
7functions described in Section 4 of this Act, shall be issued a
8license by the Department, nor shall the Secretary of State
9approve or accept articles of incorporation for such a
10corporation.
11    (b) Pursuant to subparagraph (a) of paragraph (2) of
12Section 3.6 of the Professional Service Corporation Act and
13Section 2 of the Medical Corporation Act, a person licensed
14under this Act may not own a corporation for the purposes of
15practicing medicine.
16    (c) Pursuant to paragraph (2) of subsection (a) of Section
1713 of the Professional Limited Liability Company Act, a person
18licensed under this Act may not own a professional limited
19liability company for the purposes of practicing medicine.
20(Source: P.A. 85-981.)
 
21    (225 ILCS 95/21)  (from Ch. 111, par. 4621)
22    (Section scheduled to be repealed on January 1, 2028)
23    Sec. 21. Grounds for disciplinary action.
24    (a) The Department may refuse to issue or to renew, or may

 

 

HB4637- 40 -LRB103 35424 SPS 65490 b

1revoke, suspend, place on probation, reprimand, or take other
2disciplinary or non-disciplinary action with regard to any
3license issued under this Act as the Department may deem
4proper, including the issuance of fines not to exceed $10,000
5for each violation, for any one or combination of the
6following causes:
7        (1) Material misstatement in furnishing information to
8    the Department.
9        (2) Violations of this Act, or the rules adopted under
10    this Act.
11        (3) Conviction by plea of guilty or nolo contendere,
12    finding of guilt, jury verdict, or entry of judgment or
13    sentencing, including, but not limited to, convictions,
14    preceding sentences of supervision, conditional discharge,
15    or first offender probation, under the laws of any
16    jurisdiction of the United States that is: (i) a felony;
17    or (ii) a misdemeanor, an essential element of which is
18    dishonesty, or that is directly related to the practice of
19    the profession.
20        (4) Making any misrepresentation for the purpose of
21    obtaining licenses.
22        (5) Professional incompetence.
23        (6) Aiding or assisting another person in violating
24    any provision of this Act or its rules.
25        (7) Failing, within 60 days, to provide information in
26    response to a written request made by the Department.

 

 

HB4637- 41 -LRB103 35424 SPS 65490 b

1        (8) Engaging in dishonorable, unethical, or
2    unprofessional conduct, as defined by rule, of a character
3    likely to deceive, defraud, or harm the public.
4        (9) Habitual or excessive use or addiction to alcohol,
5    narcotics, stimulants, or any other chemical agent or drug
6    that results in a physician assistant's inability to
7    practice with reasonable judgment, skill, or safety.
8        (10) Discipline by another U.S. jurisdiction or
9    foreign nation, if at least one of the grounds for
10    discipline is the same or substantially equivalent to
11    those set forth in this Section.
12        (11) Directly or indirectly giving to or receiving
13    from any person, firm, corporation, partnership, or
14    association any fee, commission, rebate or other form of
15    compensation for any professional services not actually or
16    personally rendered. Nothing in this paragraph (11)
17    affects any bona fide independent contractor or employment
18    arrangements, which may include provisions for
19    compensation, health insurance, pension, or other
20    employment benefits, with persons or entities authorized
21    under this Act for the provision of services within the
22    scope of the licensee's practice under this Act.
23        (12) A finding by the Board that the licensee, after
24    having his or her license placed on probationary status,
25    has violated the terms of probation.
26        (13) Abandonment of a patient.

 

 

HB4637- 42 -LRB103 35424 SPS 65490 b

1        (14) Willfully making or filing false records or
2    reports in his or her practice, including, but not limited
3    to, false records filed with State agencies or
4    departments.
5        (15) Willfully failing to report an instance of
6    suspected child abuse or neglect as required by the Abused
7    and Neglected Child Reporting Act.
8        (16) Physical illness, or mental illness or impairment
9    that results in the inability to practice the profession
10    with reasonable judgment, skill, or safety, including, but
11    not limited to, deterioration through the aging process or
12    loss of motor skill.
13        (17) Being named as a perpetrator in an indicated
14    report by the Department of Children and Family Services
15    under the Abused and Neglected Child Reporting Act, and
16    upon proof by clear and convincing evidence that the
17    licensee has caused a child to be an abused child or
18    neglected child as defined in the Abused and Neglected
19    Child Reporting Act.
20        (18) (Blank).
21        (19) Gross negligence resulting in permanent injury or
22    death of a patient.
23        (20) Employment of fraud, deception or any unlawful
24    means in applying for or securing a license as a physician
25    assistant.
26        (21) Exceeding the authority delegated to him or her

 

 

HB4637- 43 -LRB103 35424 SPS 65490 b

1    by his or her collaborating physician in a written
2    collaborative agreement, when the agreement is required
3    under this Act.
4        (22) Immoral conduct in the commission of any act,
5    such as sexual abuse, sexual misconduct, or sexual
6    exploitation related to the licensee's practice.
7        (23) Violation of the Health Care Worker Self-Referral
8    Act.
9        (24) Practicing under a false or assumed name, except
10    as provided by law.
11        (25) Making a false or misleading statement regarding
12    his or her skill or the efficacy or value of the medicine,
13    treatment, or remedy prescribed by him or her in the
14    course of treatment.
15        (26) Allowing another person to use his or her license
16    to practice.
17        (27) Prescribing, selling, administering,
18    distributing, giving, or self-administering a drug
19    classified as a controlled substance for other than
20    medically accepted therapeutic purposes.
21        (28) Promotion of the sale of drugs, devices,
22    appliances, or goods provided for a patient in a manner to
23    exploit the patient for financial gain.
24        (29) A pattern of practice or other behavior that
25    demonstrates incapacity or incompetence to practice under
26    this Act.

 

 

HB4637- 44 -LRB103 35424 SPS 65490 b

1        (30) Violating State or federal laws or regulations
2    relating to controlled substances or other legend drugs or
3    ephedra as defined in the Ephedra Prohibition Act.
4        (31) (Blank). Exceeding the prescriptive authority
5    delegated by the collaborating physician or violating the
6    written collaborative agreement delegating that authority.
7        (32) (Blank). Practicing without providing to the
8    Department a notice of collaboration or delegation of
9    prescriptive authority.
10        (33) Failure to establish and maintain records of
11    patient care and treatment as required by law.
12        (34) Attempting to subvert or cheat on the examination
13    of the National Commission on Certification of Physician
14    Assistants or its successor agency.
15        (35) Willfully or negligently violating the
16    confidentiality between physician assistant and patient,
17    except as required by law.
18        (36) Willfully failing to report an instance of
19    suspected abuse, neglect, financial exploitation, or
20    self-neglect of an eligible adult as defined in and
21    required by the Adult Protective Services Act.
22        (37) Being named as an abuser in a verified report by
23    the Department on Aging under the Adult Protective
24    Services Act and upon proof by clear and convincing
25    evidence that the licensee abused, neglected, or
26    financially exploited an eligible adult as defined in the

 

 

HB4637- 45 -LRB103 35424 SPS 65490 b

1    Adult Protective Services Act.
2        (38) Failure to report to the Department an adverse
3    final action taken against him or her by another licensing
4    jurisdiction of the United States or a foreign state or
5    country, a peer review body, a health care institution, a
6    professional society or association, a governmental
7    agency, a law enforcement agency, or a court acts or
8    conduct similar to acts or conduct that would constitute
9    grounds for action under this Section.
10        (39) Failure to provide copies of records of patient
11    care or treatment, except as required by law.
12        (40) (Blank). Entering into an excessive number of
13    written collaborative agreements with licensed physicians
14    resulting in an inability to adequately collaborate.
15        (41) (Blank). Repeated failure to adequately
16    collaborate with a collaborating physician.
17        (42) Violating the Compassionate Use of Medical
18    Cannabis Program Act.
19    (b) The Department may, without a hearing, refuse to issue
20or renew or may suspend the license of any person who fails to
21file a return, or to pay the tax, penalty or interest shown in
22a filed return, or to pay any final assessment of the tax,
23penalty, or interest as required by any tax Act administered
24by the Illinois Department of Revenue, until such time as the
25requirements of any such tax Act are satisfied.
26    (b-5) The Department shall not revoke, suspend, summarily

 

 

HB4637- 46 -LRB103 35424 SPS 65490 b

1suspend, place on prohibition, reprimand, refuse to issue or
2renew, or take any other disciplinary or non-disciplinary
3action against the license or permit issued under this Act to
4practice as a physician assistant based solely upon the
5physician assistant providing, authorizing, recommending,
6aiding, assisting, referring for, or otherwise participating
7in any health care service, so long as the care was not
8unlawful under the laws of this State, regardless of whether
9the patient was a resident of this State or another state.
10    (b-10) The Department shall not revoke, suspend, summarily
11suspend, place on prohibition, reprimand, refuse to issue or
12renew, or take any other disciplinary or non-disciplinary
13action against the license or permit issued under this Act to
14practice as a physician assistant based upon the physician
15assistant's license being revoked or suspended, or the
16physician assistant being otherwise disciplined by any other
17state, if that revocation, suspension, or other form of
18discipline was based solely on the physician assistant
19violating another state's laws prohibiting the provision of,
20authorization of, recommendation of, aiding or assisting in,
21referring for, or participation in any health care service if
22that health care service as provided would not have been
23unlawful under the laws of this State and is consistent with
24the standards of conduct for a physician assistant practicing
25in Illinois.
26    (b-15) The conduct specified in subsections (b-5) and

 

 

HB4637- 47 -LRB103 35424 SPS 65490 b

1(b-10) shall not constitute grounds for suspension under
2Section 22.13.
3    (b-20) An applicant seeking licensure, certification, or
4authorization pursuant to this Act who has been subject to
5disciplinary action by a duly authorized professional
6disciplinary agency of another jurisdiction solely on the
7basis of having provided, authorized, recommended, aided,
8assisted, referred for, or otherwise participated in health
9care shall not be denied such licensure, certification, or
10authorization, unless the Department determines that such
11action would have constituted professional misconduct in this
12State; however, nothing in this Section shall be construed as
13prohibiting the Department from evaluating the conduct of such
14applicant and making a determination regarding the licensure,
15certification, or authorization to practice a profession under
16this Act.
17    (c) The determination by a circuit court that a licensee
18is subject to involuntary admission or judicial admission as
19provided in the Mental Health and Developmental Disabilities
20Code operates as an automatic suspension. The suspension will
21end only upon a finding by a court that the patient is no
22longer subject to involuntary admission or judicial admission
23and issues an order so finding and discharging the patient,
24and upon the recommendation of the Board to the Secretary that
25the licensee be allowed to resume his or her practice.
26    (d) In enforcing this Section, the Department upon a

 

 

HB4637- 48 -LRB103 35424 SPS 65490 b

1showing of a possible violation may compel an individual
2licensed to practice under this Act, or who has applied for
3licensure under this Act, to submit to a mental or physical
4examination, or both, which may include a substance abuse or
5sexual offender evaluation, as required by and at the expense
6of the Department.
7    The Department shall specifically designate the examining
8physician licensed to practice medicine in all of its branches
9or, if applicable, the multidisciplinary team involved in
10providing the mental or physical examination or both. The
11multidisciplinary team shall be led by a physician licensed to
12practice medicine in all of its branches and may consist of one
13or more or a combination of physicians licensed to practice
14medicine in all of its branches, licensed clinical
15psychologists, licensed clinical social workers, licensed
16clinical professional counselors, and other professional and
17administrative staff. Any examining physician or member of the
18multidisciplinary team may require any person ordered to
19submit to an examination pursuant to this Section to submit to
20any additional supplemental testing deemed necessary to
21complete any examination or evaluation process, including, but
22not limited to, blood testing, urinalysis, psychological
23testing, or neuropsychological testing.
24    The Department may order the examining physician or any
25member of the multidisciplinary team to provide to the
26Department any and all records, including business records,

 

 

HB4637- 49 -LRB103 35424 SPS 65490 b

1that relate to the examination and evaluation, including any
2supplemental testing performed.
3    The Department may order the examining physician or any
4member of the multidisciplinary team to present testimony
5concerning the mental or physical examination of the licensee
6or applicant. No information, report, record, or other
7documents in any way related to the examination shall be
8excluded by reason of any common law or statutory privilege
9relating to communications between the licensee or applicant
10and the examining physician or any member of the
11multidisciplinary team. No authorization is necessary from the
12licensee or applicant ordered to undergo an examination for
13the examining physician or any member of the multidisciplinary
14team to provide information, reports, records, or other
15documents or to provide any testimony regarding the
16examination and evaluation.
17    The individual to be examined may have, at his or her own
18expense, another physician of his or her choice present during
19all aspects of this examination. However, that physician shall
20be present only to observe and may not interfere in any way
21with the examination.
22     Failure of an individual to submit to a mental or physical
23examination, when ordered, shall result in an automatic
24suspension of his or her license until the individual submits
25to the examination.
26    If the Department finds an individual unable to practice

 

 

HB4637- 50 -LRB103 35424 SPS 65490 b

1because of the reasons set forth in this Section, the
2Department may require that individual to submit to care,
3counseling, or treatment by physicians approved or designated
4by the Department, as a condition, term, or restriction for
5continued, reinstated, or renewed licensure to practice; or,
6in lieu of care, counseling, or treatment, the Department may
7file a complaint to immediately suspend, revoke, or otherwise
8discipline the license of the individual. An individual whose
9license was granted, continued, reinstated, renewed,
10disciplined, or supervised subject to such terms, conditions,
11or restrictions, and who fails to comply with such terms,
12conditions, or restrictions, shall be referred to the
13Secretary for a determination as to whether the individual
14shall have his or her license suspended immediately, pending a
15hearing by the Department.
16    In instances in which the Secretary immediately suspends a
17person's license under this Section, a hearing on that
18person's license must be convened by the Department within 30
19days after the suspension and completed without appreciable
20delay. The Department shall have the authority to review the
21subject individual's record of treatment and counseling
22regarding the impairment to the extent permitted by applicable
23federal statutes and regulations safeguarding the
24confidentiality of medical records.
25    An individual licensed under this Act and affected under
26this Section shall be afforded an opportunity to demonstrate

 

 

HB4637- 51 -LRB103 35424 SPS 65490 b

1to the Department that he or she can resume practice in
2compliance with acceptable and prevailing standards under the
3provisions of his or her license.
4    (e) An individual or organization acting in good faith,
5and not in a willful and wanton manner, in complying with this
6Section by providing a report or other information to the
7Board, by assisting in the investigation or preparation of a
8report or information, by participating in proceedings of the
9Board, or by serving as a member of the Board, shall not be
10subject to criminal prosecution or civil damages as a result
11of such actions.
12    (f) Members of the Board shall be indemnified by the State
13for any actions occurring within the scope of services on the
14Board, done in good faith and not willful and wanton in nature.
15The Attorney General shall defend all such actions unless he
16or she determines either that there would be a conflict of
17interest in such representation or that the actions complained
18of were not in good faith or were willful and wanton.
19    If the Attorney General declines representation, the
20member has the right to employ counsel of his or her choice,
21whose fees shall be provided by the State, after approval by
22the Attorney General, unless there is a determination by a
23court that the member's actions were not in good faith or were
24willful and wanton.
25    The member must notify the Attorney General within 7 days
26after receipt of notice of the initiation of any action

 

 

HB4637- 52 -LRB103 35424 SPS 65490 b

1involving services of the Board. Failure to so notify the
2Attorney General constitutes an absolute waiver of the right
3to a defense and indemnification.
4    The Attorney General shall determine, within 7 days after
5receiving such notice, whether he or she will undertake to
6represent the member.
7    (g) The Department may adopt rules to implement the
8changes made by this amendatory Act of the 102nd General
9Assembly.
10(Source: P.A. 101-363, eff. 8-9-19; 102-558, eff. 8-20-21;
11102-1117, eff. 1-13-23.)
 
12    Section 10. The Illinois Controlled Substances Act is
13amended by changing Sections 102 and 303.05 as follows:
 
14    (720 ILCS 570/102)  (from Ch. 56 1/2, par. 1102)
15    Sec. 102. Definitions. As used in this Act, unless the
16context otherwise requires:
17    (a) "Addict" means any person who habitually uses any
18drug, chemical, substance or dangerous drug other than alcohol
19so as to endanger the public morals, health, safety or welfare
20or who is so far addicted to the use of a dangerous drug or
21controlled substance other than alcohol as to have lost the
22power of self control with reference to his or her addiction.
23    (b) "Administer" means the direct application of a
24controlled substance, whether by injection, inhalation,

 

 

HB4637- 53 -LRB103 35424 SPS 65490 b

1ingestion, or any other means, to the body of a patient,
2research subject, or animal (as defined by the Humane
3Euthanasia in Animal Shelters Act) by:
4        (1) a practitioner (or, in his or her presence, by his
5    or her authorized agent),
6        (2) the patient or research subject pursuant to an
7    order, or
8        (3) a euthanasia technician as defined by the Humane
9    Euthanasia in Animal Shelters Act.
10    (c) "Agent" means an authorized person who acts on behalf
11of or at the direction of a manufacturer, distributor,
12dispenser, prescriber, or practitioner. It does not include a
13common or contract carrier, public warehouseman or employee of
14the carrier or warehouseman.
15    (c-1) "Anabolic Steroids" means any drug or hormonal
16substance, chemically and pharmacologically related to
17testosterone (other than estrogens, progestins,
18corticosteroids, and dehydroepiandrosterone), and includes:
19    (i) 3[beta],17-dihydroxy-5a-androstane, 
20    (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, 
21    (iii) 5[alpha]-androstan-3,17-dione, 
22    (iv) 1-androstenediol (3[beta], 
23        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
24    (v) 1-androstenediol (3[alpha], 
25        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
26    (vi) 4-androstenediol  

 

 

HB4637- 54 -LRB103 35424 SPS 65490 b

1        (3[beta],17[beta]-dihydroxy-androst-4-ene), 
2    (vii) 5-androstenediol  
3        (3[beta],17[beta]-dihydroxy-androst-5-ene), 
4    (viii) 1-androstenedione  
5        ([5alpha]-androst-1-en-3,17-dione), 
6    (ix) 4-androstenedione  
7        (androst-4-en-3,17-dione), 
8    (x) 5-androstenedione  
9        (androst-5-en-3,17-dione), 
10    (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- 
11        hydroxyandrost-4-en-3-one), 
12    (xii) boldenone (17[beta]-hydroxyandrost- 
13        1,4,-diene-3-one), 
14    (xiii) boldione (androsta-1,4- 
15        diene-3,17-dione), 
16    (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 
17        [beta]-hydroxyandrost-4-en-3-one), 
18    (xv) clostebol (4-chloro-17[beta]- 
19        hydroxyandrost-4-en-3-one), 
20    (xvi) dehydrochloromethyltestosterone (4-chloro- 
21        17[beta]-hydroxy-17[alpha]-methyl- 
22        androst-1,4-dien-3-one), 
23    (xvii) desoxymethyltestosterone 
24    (17[alpha]-methyl-5[alpha] 
25        -androst-2-en-17[beta]-ol)(a.k.a., madol), 
26    (xviii) [delta]1-dihydrotestosterone (a.k.a.  

 

 

HB4637- 55 -LRB103 35424 SPS 65490 b

1        '1-testosterone') (17[beta]-hydroxy- 
2        5[alpha]-androst-1-en-3-one), 
3    (xix) 4-dihydrotestosterone (17[beta]-hydroxy- 
4        androstan-3-one), 
5    (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- 
6        5[alpha]-androstan-3-one), 
7    (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- 
8        hydroxyestr-4-ene), 
9    (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- 
10        1[beta],17[beta]-dihydroxyandrost-4-en-3-one), 
11    (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], 
12        17[beta]-dihydroxyandrost-1,4-dien-3-one), 
13    (xxiv) furazabol (17[alpha]-methyl-17[beta]- 
14        hydroxyandrostano[2,3-c]-furazan), 
15    (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one, 
16    (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- 
17        androst-4-en-3-one), 
18    (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- 
19        dihydroxy-estr-4-en-3-one), 
20    (xxviii) mestanolone (17[alpha]-methyl-17[beta]- 
21        hydroxy-5-androstan-3-one), 
22    (xxix) mesterolone (1amethyl-17[beta]-hydroxy- 
23        [5a]-androstan-3-one), 
24    (xxx) methandienone (17[alpha]-methyl-17[beta]- 
25        hydroxyandrost-1,4-dien-3-one), 
26    (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- 

 

 

HB4637- 56 -LRB103 35424 SPS 65490 b

1        dihydroxyandrost-5-ene), 
2    (xxxii) methenolone (1-methyl-17[beta]-hydroxy- 
3        5[alpha]-androst-1-en-3-one), 
4    (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- 
5        dihydroxy-5a-androstane, 
6    (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy 
7        -5a-androstane, 
8    (xxxv) 17[alpha]-methyl-3[beta],17[beta]- 
9        dihydroxyandrost-4-ene), 
10    (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- 
11        methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), 
12    (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- 
13        hydroxyestra-4,9(10)-dien-3-one), 
14    (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- 
15        hydroxyestra-4,9-11-trien-3-one), 
16    (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- 
17        hydroxyandrost-4-en-3-one), 
18    (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- 
19        hydroxyestr-4-en-3-one), 
20    (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone  
21        (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- 
22        androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- 
23        1-testosterone'), 
24    (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), 
25    (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- 
26        dihydroxyestr-4-ene), 

 

 

HB4637- 57 -LRB103 35424 SPS 65490 b

1    (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- 
2        dihydroxyestr-4-ene), 
3    (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- 
4        dihydroxyestr-5-ene), 
5    (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- 
6        dihydroxyestr-5-ene), 
7    (xlvii) 19-nor-4,9(10)-androstadienedione  
8        (estra-4,9(10)-diene-3,17-dione), 
9    (xlviii) 19-nor-4-androstenedione (estr-4- 
10        en-3,17-dione), 
11    (xlix) 19-nor-5-androstenedione (estr-5- 
12        en-3,17-dione), 
13    (l) norbolethone (13[beta], 17a-diethyl-17[beta]- 
14        hydroxygon-4-en-3-one), 
15    (li) norclostebol (4-chloro-17[beta]- 
16        hydroxyestr-4-en-3-one), 
17    (lii) norethandrolone (17[alpha]-ethyl-17[beta]- 
18        hydroxyestr-4-en-3-one), 
19    (liii) normethandrolone (17[alpha]-methyl-17[beta]- 
20        hydroxyestr-4-en-3-one), 
21    (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- 
22        2-oxa-5[alpha]-androstan-3-one), 
23    (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- 
24        dihydroxyandrost-4-en-3-one), 
25    (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- 
26        17[beta]-hydroxy-(5[alpha]-androstan-3-one), 

 

 

HB4637- 58 -LRB103 35424 SPS 65490 b

1    (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- 
2        (5[alpha]-androst-2-eno[3,2-c]-pyrazole), 
3    (lviii) stenbolone (17[beta]-hydroxy-2-methyl- 
4        (5[alpha]-androst-1-en-3-one), 
5    (lix) testolactone (13-hydroxy-3-oxo-13,17- 
6        secoandrosta-1,4-dien-17-oic 
7        acid lactone), 
8    (lx) testosterone (17[beta]-hydroxyandrost- 
9        4-en-3-one), 
10    (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- 
11        diethyl-17[beta]-hydroxygon- 
12        4,9,11-trien-3-one), 
13    (lxii) trenbolone (17[beta]-hydroxyestr-4,9, 
14        11-trien-3-one). 
15    Any person who is otherwise lawfully in possession of an
16anabolic steroid, or who otherwise lawfully manufactures,
17distributes, dispenses, delivers, or possesses with intent to
18deliver an anabolic steroid, which anabolic steroid is
19expressly intended for and lawfully allowed to be administered
20through implants to livestock or other nonhuman species, and
21which is approved by the Secretary of Health and Human
22Services for such administration, and which the person intends
23to administer or have administered through such implants,
24shall not be considered to be in unauthorized possession or to
25unlawfully manufacture, distribute, dispense, deliver, or
26possess with intent to deliver such anabolic steroid for

 

 

HB4637- 59 -LRB103 35424 SPS 65490 b

1purposes of this Act.
2    (d) "Administration" means the Drug Enforcement
3Administration, United States Department of Justice, or its
4successor agency.
5    (d-5) "Clinical Director, Prescription Monitoring Program"
6means a Department of Human Services administrative employee
7licensed to either prescribe or dispense controlled substances
8who shall run the clinical aspects of the Department of Human
9Services Prescription Monitoring Program and its Prescription
10Information Library.
11    (d-10) "Compounding" means the preparation and mixing of
12components, excluding flavorings, (1) as the result of a
13prescriber's prescription drug order or initiative based on
14the prescriber-patient-pharmacist relationship in the course
15of professional practice or (2) for the purpose of, or
16incident to, research, teaching, or chemical analysis and not
17for sale or dispensing. "Compounding" includes the preparation
18of drugs or devices in anticipation of receiving prescription
19drug orders based on routine, regularly observed dispensing
20patterns. Commercially available products may be compounded
21for dispensing to individual patients only if both of the
22following conditions are met: (i) the commercial product is
23not reasonably available from normal distribution channels in
24a timely manner to meet the patient's needs and (ii) the
25prescribing practitioner has requested that the drug be
26compounded.

 

 

HB4637- 60 -LRB103 35424 SPS 65490 b

1    (e) "Control" means to add a drug or other substance, or
2immediate precursor, to a Schedule whether by transfer from
3another Schedule or otherwise.
4    (f) "Controlled Substance" means (i) a drug, substance,
5immediate precursor, or synthetic drug in the Schedules of
6Article II of this Act or (ii) a drug or other substance, or
7immediate precursor, designated as a controlled substance by
8the Department through administrative rule. The term does not
9include distilled spirits, wine, malt beverages, or tobacco,
10as those terms are defined or used in the Liquor Control Act of
111934 and the Tobacco Products Tax Act of 1995.
12    (f-5) "Controlled substance analog" means a substance:
13        (1) the chemical structure of which is substantially
14    similar to the chemical structure of a controlled
15    substance in Schedule I or II;
16        (2) which has a stimulant, depressant, or
17    hallucinogenic effect on the central nervous system that
18    is substantially similar to or greater than the stimulant,
19    depressant, or hallucinogenic effect on the central
20    nervous system of a controlled substance in Schedule I or
21    II; or
22        (3) with respect to a particular person, which such
23    person represents or intends to have a stimulant,
24    depressant, or hallucinogenic effect on the central
25    nervous system that is substantially similar to or greater
26    than the stimulant, depressant, or hallucinogenic effect

 

 

HB4637- 61 -LRB103 35424 SPS 65490 b

1    on the central nervous system of a controlled substance in
2    Schedule I or II.
3    (g) "Counterfeit substance" means a controlled substance,
4which, or the container or labeling of which, without
5authorization bears the trademark, trade name, or other
6identifying mark, imprint, number or device, or any likeness
7thereof, of a manufacturer, distributor, or dispenser other
8than the person who in fact manufactured, distributed, or
9dispensed the substance.
10    (h) "Deliver" or "delivery" means the actual, constructive
11or attempted transfer of possession of a controlled substance,
12with or without consideration, whether or not there is an
13agency relationship. "Deliver" or "delivery" does not include
14the donation of drugs to the extent permitted under the
15Illinois Drug Reuse Opportunity Program Act.
16    (i) "Department" means the Illinois Department of Human
17Services (as successor to the Department of Alcoholism and
18Substance Abuse) or its successor agency.
19    (j) (Blank).
20    (k) "Department of Corrections" means the Department of
21Corrections of the State of Illinois or its successor agency.
22    (l) "Department of Financial and Professional Regulation"
23means the Department of Financial and Professional Regulation
24of the State of Illinois or its successor agency.
25    (m) "Depressant" means any drug that (i) causes an overall
26depression of central nervous system functions, (ii) causes

 

 

HB4637- 62 -LRB103 35424 SPS 65490 b

1impaired consciousness and awareness, and (iii) can be
2habit-forming or lead to a substance abuse problem, including,
3but not limited to, alcohol, cannabis and its active
4principles and their analogs, benzodiazepines and their
5analogs, barbiturates and their analogs, opioids (natural and
6synthetic) and their analogs, and chloral hydrate and similar
7sedative hypnotics.
8    (n) (Blank).
9    (o) "Director" means the Director of the Illinois State
10Police or his or her designated agents.
11    (p) "Dispense" means to deliver a controlled substance to
12an ultimate user or research subject by or pursuant to the
13lawful order of a prescriber, including the prescribing,
14administering, packaging, labeling, or compounding necessary
15to prepare the substance for that delivery.
16    (q) "Dispenser" means a practitioner who dispenses.
17    (r) "Distribute" means to deliver, other than by
18administering or dispensing, a controlled substance.
19    (s) "Distributor" means a person who distributes.
20    (t) "Drug" means (1) substances recognized as drugs in the
21official United States Pharmacopoeia, Official Homeopathic
22Pharmacopoeia of the United States, or official National
23Formulary, or any supplement to any of them; (2) substances
24intended for use in diagnosis, cure, mitigation, treatment, or
25prevention of disease in man or animals; (3) substances (other
26than food) intended to affect the structure of any function of

 

 

HB4637- 63 -LRB103 35424 SPS 65490 b

1the body of man or animals and (4) substances intended for use
2as a component of any article specified in clause (1), (2), or
3(3) of this subsection. It does not include devices or their
4components, parts, or accessories.
5    (t-3) "Electronic health record" or "EHR" means an
6electronic record of health-related information on an
7individual that is created, gathered, managed, and consulted
8by authorized health care clinicians and staff.
9    (t-3.5) "Electronic health record system" or "EHR system"
10means any computer-based system or combination of federally
11certified Health IT Modules (defined at 42 CFR 170.102 or its
12successor) used as a repository for electronic health records
13and accessed or updated by a prescriber or authorized
14surrogate in the ordinary course of his or her medical
15practice. For purposes of connecting to the Prescription
16Information Library maintained by the Bureau of Pharmacy and
17Clinical Support Systems or its successor, an EHR system may
18connect to the Prescription Information Library directly or
19through all or part of a computer program or system that is a
20federally certified Health IT Module maintained by a third
21party and used by the EHR system to secure access to the
22database.
23    (t-4) "Emergency medical services personnel" has the
24meaning ascribed to it in the Emergency Medical Services (EMS)
25Systems Act.
26    (t-5) "Euthanasia agency" means an entity certified by the

 

 

HB4637- 64 -LRB103 35424 SPS 65490 b

1Department of Financial and Professional Regulation for the
2purpose of animal euthanasia that holds an animal control
3facility license or animal shelter license under the Animal
4Welfare Act. A euthanasia agency is authorized to purchase,
5store, possess, and utilize Schedule II nonnarcotic and
6Schedule III nonnarcotic drugs for the sole purpose of animal
7euthanasia.
8    (t-10) "Euthanasia drugs" means Schedule II or Schedule
9III substances (nonnarcotic controlled substances) that are
10used by a euthanasia agency for the purpose of animal
11euthanasia.
12    (u) "Good faith" means the prescribing or dispensing of a
13controlled substance by a practitioner in the regular course
14of professional treatment to or for any person who is under his
15or her treatment for a pathology or condition other than that
16individual's physical or psychological dependence upon or
17addiction to a controlled substance, except as provided
18herein: and application of the term to a pharmacist shall mean
19the dispensing of a controlled substance pursuant to the
20prescriber's order which in the professional judgment of the
21pharmacist is lawful. The pharmacist shall be guided by
22accepted professional standards, including, but not limited
23to, the following, in making the judgment:
24        (1) lack of consistency of prescriber-patient
25    relationship,
26        (2) frequency of prescriptions for same drug by one

 

 

HB4637- 65 -LRB103 35424 SPS 65490 b

1    prescriber for large numbers of patients,
2        (3) quantities beyond those normally prescribed,
3        (4) unusual dosages (recognizing that there may be
4    clinical circumstances where more or less than the usual
5    dose may be used legitimately),
6        (5) unusual geographic distances between patient,
7    pharmacist and prescriber,
8        (6) consistent prescribing of habit-forming drugs.
9    (u-0.5) "Hallucinogen" means a drug that causes markedly
10altered sensory perception leading to hallucinations of any
11type.
12    (u-1) "Home infusion services" means services provided by
13a pharmacy in compounding solutions for direct administration
14to a patient in a private residence, long-term care facility,
15or hospice setting by means of parenteral, intravenous,
16intramuscular, subcutaneous, or intraspinal infusion.
17    (u-5) "Illinois State Police" means the Illinois State
18Police or its successor agency.
19    (v) "Immediate precursor" means a substance:
20        (1) which the Department has found to be and by rule
21    designated as being a principal compound used, or produced
22    primarily for use, in the manufacture of a controlled
23    substance;
24        (2) which is an immediate chemical intermediary used
25    or likely to be used in the manufacture of such controlled
26    substance; and

 

 

HB4637- 66 -LRB103 35424 SPS 65490 b

1        (3) the control of which is necessary to prevent,
2    curtail or limit the manufacture of such controlled
3    substance.
4    (w) "Instructional activities" means the acts of teaching,
5educating or instructing by practitioners using controlled
6substances within educational facilities approved by the State
7Board of Education or its successor agency.
8    (x) "Local authorities" means a duly organized State,
9County or Municipal peace unit or police force.
10    (y) "Look-alike substance" means a substance, other than a
11controlled substance which (1) by overall dosage unit
12appearance, including shape, color, size, markings or lack
13thereof, taste, consistency, or any other identifying physical
14characteristic of the substance, would lead a reasonable
15person to believe that the substance is a controlled
16substance, or (2) is expressly or impliedly represented to be
17a controlled substance or is distributed under circumstances
18which would lead a reasonable person to believe that the
19substance is a controlled substance. For the purpose of
20determining whether the representations made or the
21circumstances of the distribution would lead a reasonable
22person to believe the substance to be a controlled substance
23under this clause (2) of subsection (y), the court or other
24authority may consider the following factors in addition to
25any other factor that may be relevant:
26        (a) statements made by the owner or person in control

 

 

HB4637- 67 -LRB103 35424 SPS 65490 b

1    of the substance concerning its nature, use or effect;
2        (b) statements made to the buyer or recipient that the
3    substance may be resold for profit;
4        (c) whether the substance is packaged in a manner
5    normally used for the illegal distribution of controlled
6    substances;
7        (d) whether the distribution or attempted distribution
8    included an exchange of or demand for money or other
9    property as consideration, and whether the amount of the
10    consideration was substantially greater than the
11    reasonable retail market value of the substance.
12    Clause (1) of this subsection (y) shall not apply to a
13noncontrolled substance in its finished dosage form that was
14initially introduced into commerce prior to the initial
15introduction into commerce of a controlled substance in its
16finished dosage form which it may substantially resemble.
17    Nothing in this subsection (y) prohibits the dispensing or
18distributing of noncontrolled substances by persons authorized
19to dispense and distribute controlled substances under this
20Act, provided that such action would be deemed to be carried
21out in good faith under subsection (u) if the substances
22involved were controlled substances.
23    Nothing in this subsection (y) or in this Act prohibits
24the manufacture, preparation, propagation, compounding,
25processing, packaging, advertising or distribution of a drug
26or drugs by any person registered pursuant to Section 510 of

 

 

HB4637- 68 -LRB103 35424 SPS 65490 b

1the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
2    (y-1) "Mail-order pharmacy" means a pharmacy that is
3located in a state of the United States that delivers,
4dispenses or distributes, through the United States Postal
5Service or other common carrier, to Illinois residents, any
6substance which requires a prescription.
7    (z) "Manufacture" means the production, preparation,
8propagation, compounding, conversion or processing of a
9controlled substance other than methamphetamine, either
10directly or indirectly, by extraction from substances of
11natural origin, or independently by means of chemical
12synthesis, or by a combination of extraction and chemical
13synthesis, and includes any packaging or repackaging of the
14substance or labeling of its container, except that this term
15does not include:
16        (1) by an ultimate user, the preparation or
17    compounding of a controlled substance for his or her own
18    use;
19        (2) by a practitioner, or his or her authorized agent
20    under his or her supervision, the preparation,
21    compounding, packaging, or labeling of a controlled
22    substance:
23            (a) as an incident to his or her administering or
24        dispensing of a controlled substance in the course of
25        his or her professional practice; or
26            (b) as an incident to lawful research, teaching or

 

 

HB4637- 69 -LRB103 35424 SPS 65490 b

1        chemical analysis and not for sale; or
2        (3) the packaging, repackaging, or labeling of drugs
3    only to the extent permitted under the Illinois Drug Reuse
4    Opportunity Program Act.
5    (z-1) (Blank).
6    (z-5) "Medication shopping" means the conduct prohibited
7under subsection (a) of Section 314.5 of this Act.
8    (z-10) "Mid-level practitioner" means (i) a physician
9assistant who has been delegated authority to prescribe
10through a written delegation of authority by a physician
11licensed to practice medicine in all of its branches, in
12accordance with Section 7.5 of the Physician Assistant
13Practice Act of 1987, (ii) an advanced practice registered
14nurse who has been delegated authority to prescribe through a
15written delegation of authority by a physician licensed to
16practice medicine in all of its branches or by a podiatric
17physician, in accordance with Section 65-40 of the Nurse
18Practice Act, (iii) an advanced practice registered nurse
19certified as a nurse practitioner, nurse midwife, or clinical
20nurse specialist who has been granted authority to prescribe
21by a hospital affiliate in accordance with Section 65-45 of
22the Nurse Practice Act, (iv) an animal euthanasia agency, or
23(v) a prescribing psychologist.
24    (aa) "Narcotic drug" means any of the following, whether
25produced directly or indirectly by extraction from substances
26of vegetable origin, or independently by means of chemical

 

 

HB4637- 70 -LRB103 35424 SPS 65490 b

1synthesis, or by a combination of extraction and chemical
2synthesis:
3        (1) opium, opiates, derivatives of opium and opiates,
4    including their isomers, esters, ethers, salts, and salts
5    of isomers, esters, and ethers, whenever the existence of
6    such isomers, esters, ethers, and salts is possible within
7    the specific chemical designation; however the term
8    "narcotic drug" does not include the isoquinoline
9    alkaloids of opium;
10        (2) (blank);
11        (3) opium poppy and poppy straw;
12        (4) coca leaves, except coca leaves and extracts of
13    coca leaves from which substantially all of the cocaine
14    and ecgonine, and their isomers, derivatives and salts,
15    have been removed;
16        (5) cocaine, its salts, optical and geometric isomers,
17    and salts of isomers;
18        (6) ecgonine, its derivatives, their salts, isomers,
19    and salts of isomers;
20        (7) any compound, mixture, or preparation which
21    contains any quantity of any of the substances referred to
22    in subparagraphs (1) through (6).
23    (bb) "Nurse" means a registered nurse licensed under the
24Nurse Practice Act.
25    (cc) (Blank).
26    (dd) "Opiate" means any substance having an addiction

 

 

HB4637- 71 -LRB103 35424 SPS 65490 b

1forming or addiction sustaining liability similar to morphine
2or being capable of conversion into a drug having addiction
3forming or addiction sustaining liability.
4    (ee) "Opium poppy" means the plant of the species Papaver
5somniferum L., except its seeds.
6    (ee-5) "Oral dosage" means a tablet, capsule, elixir, or
7solution or other liquid form of medication intended for
8administration by mouth, but the term does not include a form
9of medication intended for buccal, sublingual, or transmucosal
10administration.
11    (ff) "Parole and Pardon Board" means the Parole and Pardon
12Board of the State of Illinois or its successor agency.
13    (gg) "Person" means any individual, corporation,
14mail-order pharmacy, government or governmental subdivision or
15agency, business trust, estate, trust, partnership or
16association, or any other entity.
17    (hh) "Pharmacist" means any person who holds a license or
18certificate of registration as a registered pharmacist, a
19local registered pharmacist or a registered assistant
20pharmacist under the Pharmacy Practice Act.
21    (ii) "Pharmacy" means any store, ship or other place in
22which pharmacy is authorized to be practiced under the
23Pharmacy Practice Act.
24    (ii-5) "Pharmacy shopping" means the conduct prohibited
25under subsection (b) of Section 314.5 of this Act.
26    (ii-10) "Physician" (except when the context otherwise

 

 

HB4637- 72 -LRB103 35424 SPS 65490 b

1requires) means a person licensed to practice medicine in all
2of its branches.
3    (jj) "Poppy straw" means all parts, except the seeds, of
4the opium poppy, after mowing.
5    (kk) "Practitioner" means a physician licensed to practice
6medicine in all its branches, dentist, optometrist, podiatric
7physician, veterinarian, scientific investigator, pharmacist,
8physician assistant, advanced practice registered nurse,
9licensed practical nurse, registered nurse, emergency medical
10services personnel, hospital, laboratory, or pharmacy, or
11other person licensed, registered, or otherwise lawfully
12permitted by the United States or this State to distribute,
13dispense, conduct research with respect to, administer or use
14in teaching or chemical analysis, a controlled substance in
15the course of professional practice or research.
16    (ll) "Pre-printed prescription" means a written
17prescription upon which the designated drug has been indicated
18prior to the time of issuance; the term does not mean a written
19prescription that is individually generated by machine or
20computer in the prescriber's office.
21    (mm) "Prescriber" means a physician licensed to practice
22medicine in all its branches, dentist, optometrist,
23prescribing psychologist licensed under Section 4.2 of the
24Clinical Psychologist Licensing Act with prescriptive
25authority delegated under Section 4.3 of the Clinical
26Psychologist Licensing Act, podiatric physician, or

 

 

HB4637- 73 -LRB103 35424 SPS 65490 b

1veterinarian who issues a prescription, a physician assistant
2who issues a prescription for a controlled substance in
3accordance with Section 303.05, a written delegation, and a
4written collaborative agreement required under Section 7.5 of
5the Physician Assistant Practice Act of 1987, an advanced
6practice registered nurse with prescriptive authority
7delegated under Section 65-40 of the Nurse Practice Act and in
8accordance with Section 303.05, a written delegation, and a
9written collaborative agreement under Section 65-35 of the
10Nurse Practice Act, an advanced practice registered nurse
11certified as a nurse practitioner, nurse midwife, or clinical
12nurse specialist who has been granted authority to prescribe
13by a hospital affiliate in accordance with Section 65-45 of
14the Nurse Practice Act and in accordance with Section 303.05,
15or an advanced practice registered nurse certified as a nurse
16practitioner, nurse midwife, or clinical nurse specialist who
17has full practice authority pursuant to Section 65-43 of the
18Nurse Practice Act.
19    (nn) "Prescription" means a written, facsimile, or oral
20order, or an electronic order that complies with applicable
21federal requirements, of a physician licensed to practice
22medicine in all its branches, dentist, podiatric physician or
23veterinarian for any controlled substance, of an optometrist
24in accordance with Section 15.1 of the Illinois Optometric
25Practice Act of 1987, of a prescribing psychologist licensed
26under Section 4.2 of the Clinical Psychologist Licensing Act

 

 

HB4637- 74 -LRB103 35424 SPS 65490 b

1with prescriptive authority delegated under Section 4.3 of the
2Clinical Psychologist Licensing Act, of a physician assistant
3for a controlled substance in accordance with Section 303.05,
4a written delegation, and a written collaborative agreement
5required under Section 7.5 of the Physician Assistant Practice
6Act of 1987, of an advanced practice registered nurse with
7prescriptive authority delegated under Section 65-40 of the
8Nurse Practice Act who issues a prescription for a controlled
9substance in accordance with Section 303.05, a written
10delegation, and a written collaborative agreement under
11Section 65-35 of the Nurse Practice Act, of an advanced
12practice registered nurse certified as a nurse practitioner,
13nurse midwife, or clinical nurse specialist who has been
14granted authority to prescribe by a hospital affiliate in
15accordance with Section 65-45 of the Nurse Practice Act and in
16accordance with Section 303.05 when required by law, or of an
17advanced practice registered nurse certified as a nurse
18practitioner, nurse midwife, or clinical nurse specialist who
19has full practice authority pursuant to Section 65-43 of the
20Nurse Practice Act.
21    (nn-5) "Prescription Information Library" (PIL) means an
22electronic library that contains reported controlled substance
23data.
24    (nn-10) "Prescription Monitoring Program" (PMP) means the
25entity that collects, tracks, and stores reported data on
26controlled substances and select drugs pursuant to Section

 

 

HB4637- 75 -LRB103 35424 SPS 65490 b

1316.
2    (oo) "Production" or "produce" means manufacture,
3planting, cultivating, growing, or harvesting of a controlled
4substance other than methamphetamine.
5    (pp) "Registrant" means every person who is required to
6register under Section 302 of this Act.
7    (qq) "Registry number" means the number assigned to each
8person authorized to handle controlled substances under the
9laws of the United States and of this State.
10    (qq-5) "Secretary" means, as the context requires, either
11the Secretary of the Department or the Secretary of the
12Department of Financial and Professional Regulation, and the
13Secretary's designated agents.
14    (rr) "State" includes the State of Illinois and any state,
15district, commonwealth, territory, insular possession thereof,
16and any area subject to the legal authority of the United
17States of America.
18    (rr-5) "Stimulant" means any drug that (i) causes an
19overall excitation of central nervous system functions, (ii)
20causes impaired consciousness and awareness, and (iii) can be
21habit-forming or lead to a substance abuse problem, including,
22but not limited to, amphetamines and their analogs,
23methylphenidate and its analogs, cocaine, and phencyclidine
24and its analogs.
25    (rr-10) "Synthetic drug" includes, but is not limited to,
26any synthetic cannabinoids or piperazines or any synthetic

 

 

HB4637- 76 -LRB103 35424 SPS 65490 b

1cathinones as provided for in Schedule I.
2    (ss) "Ultimate user" means a person who lawfully possesses
3a controlled substance for his or her own use or for the use of
4a member of his or her household or for administering to an
5animal owned by him or her or by a member of his or her
6household.
7(Source: P.A. 101-666, eff. 1-1-22; 102-389, eff. 1-1-22;
8102-538, eff. 8-20-21; 102-813, eff. 5-13-22.)
 
9    (720 ILCS 570/303.05)
10    Sec. 303.05. Mid-level practitioner registration.
11    (a) The Department of Financial and Professional
12Regulation shall register licensed physician assistants,
13licensed advanced practice registered nurses, and prescribing
14psychologists licensed under Section 4.2 of the Clinical
15Psychologist Licensing Act to prescribe and dispense
16controlled substances under Section 303 and euthanasia
17agencies to purchase, store, or administer animal euthanasia
18drugs under the following circumstances:
19        (1) with respect to physician assistants,
20            (A) the physician assistant has been delegated
21        written authority to prescribe any Schedule III
22        through V controlled substances by a physician
23        licensed to practice medicine in all its branches in
24        accordance with Section 7.5 of the Physician Assistant
25        Practice Act of 1987; and the physician assistant has

 

 

HB4637- 77 -LRB103 35424 SPS 65490 b

1        completed the appropriate application forms and has
2        paid the required fees as set by rule; or
3            (B) the physician assistant has been delegated
4        authority by a collaborating physician licensed to
5        practice medicine in all its branches to prescribe or
6        dispense Schedule II controlled substances through a
7        written delegation of authority and under the
8        following conditions:
9                (i) Specific Schedule II controlled substances
10            by oral dosage or topical or transdermal
11            application may be delegated, provided that the
12            delegated Schedule II controlled substances are
13            routinely prescribed by the collaborating
14            physician. This delegation must identify the
15            specific Schedule II controlled substances by
16            either brand name or generic name. Schedule II
17            controlled substances to be delivered by injection
18            or other route of administration may not be
19            delegated;
20                (ii) any delegation must be of controlled
21            substances prescribed by the collaborating
22            physician;
23                (iii) all prescriptions must be limited to no
24            more than a 30-day supply, with any continuation
25            authorized only after prior approval of the
26            collaborating physician;

 

 

HB4637- 78 -LRB103 35424 SPS 65490 b

1                (iv) the physician assistant must discuss the
2            condition of any patients for whom a controlled
3            substance is prescribed monthly with the
4            delegating physician;
5            (A) (v) the physician assistant must have
6        completed the appropriate application forms and paid
7        the required fees as set by rule;
8            (B) (vi) the physician assistant must provide
9        evidence of satisfactory completion of 45 contact
10        hours in pharmacology from any physician assistant
11        program accredited by the Accreditation Review
12        Commission on Education for the Physician Assistant
13        (ARC-PA), or its predecessor agency, for any new
14        license issued with Schedule II authority after the
15        effective date of this amendatory Act of the 97th
16        General Assembly; and
17            (C) (vii) the physician assistant must annually
18        complete at least 5 hours of continuing education in
19        pharmacology;
20        (2) with respect to advanced practice registered
21    nurses who do not meet the requirements of Section 65-43
22    of the Nurse Practice Act,
23            (A) the advanced practice registered nurse has
24        been delegated authority to prescribe any Schedule III
25        through V controlled substances by a collaborating
26        physician licensed to practice medicine in all its

 

 

HB4637- 79 -LRB103 35424 SPS 65490 b

1        branches or a collaborating podiatric physician in
2        accordance with Section 65-40 of the Nurse Practice
3        Act. The advanced practice registered nurse has
4        completed the appropriate application forms and has
5        paid the required fees as set by rule; or
6            (B) the advanced practice registered nurse has
7        been delegated authority by a collaborating physician
8        licensed to practice medicine in all its branches to
9        prescribe or dispense Schedule II controlled
10        substances through a written delegation of authority
11        and under the following conditions:
12                (i) specific Schedule II controlled substances
13            by oral dosage or topical or transdermal
14            application may be delegated, provided that the
15            delegated Schedule II controlled substances are
16            routinely prescribed by the collaborating
17            physician. This delegation must identify the
18            specific Schedule II controlled substances by
19            either brand name or generic name. Schedule II
20            controlled substances to be delivered by injection
21            or other route of administration may not be
22            delegated;
23                (ii) any delegation must be of controlled
24            substances prescribed by the collaborating
25            physician;
26                (iii) all prescriptions must be limited to no

 

 

HB4637- 80 -LRB103 35424 SPS 65490 b

1            more than a 30-day supply, with any continuation
2            authorized only after prior approval of the
3            collaborating physician;
4                (iv) the advanced practice registered nurse
5            must discuss the condition of any patients for
6            whom a controlled substance is prescribed monthly
7            with the delegating physician or in the course of
8            review as required by Section 65-40 of the Nurse
9            Practice Act;
10                (v) the advanced practice registered nurse
11            must have completed the appropriate application
12            forms and paid the required fees as set by rule;
13                (vi) the advanced practice registered nurse
14            must provide evidence of satisfactory completion
15            of at least 45 graduate contact hours in
16            pharmacology for any new license issued with
17            Schedule II authority after the effective date of
18            this amendatory Act of the 97th General Assembly;
19            and
20                (vii) the advanced practice registered nurse
21            must annually complete 5 hours of continuing
22            education in pharmacology;
23        (2.5) with respect to advanced practice registered
24    nurses certified as nurse practitioners, nurse midwives,
25    or clinical nurse specialists who do not meet the
26    requirements of Section 65-43 of the Nurse Practice Act

 

 

HB4637- 81 -LRB103 35424 SPS 65490 b

1    practicing in a hospital affiliate,
2            (A) the advanced practice registered nurse
3        certified as a nurse practitioner, nurse midwife, or
4        clinical nurse specialist has been privileged to
5        prescribe any Schedule II through V controlled
6        substances by the hospital affiliate upon the
7        recommendation of the appropriate physician committee
8        of the hospital affiliate in accordance with Section
9        65-45 of the Nurse Practice Act, has completed the
10        appropriate application forms, and has paid the
11        required fees as set by rule; and
12            (B) an advanced practice registered nurse
13        certified as a nurse practitioner, nurse midwife, or
14        clinical nurse specialist has been privileged to
15        prescribe any Schedule II controlled substances by the
16        hospital affiliate upon the recommendation of the
17        appropriate physician committee of the hospital
18        affiliate, then the following conditions must be met:
19                (i) specific Schedule II controlled substances
20            by oral dosage or topical or transdermal
21            application may be designated, provided that the
22            designated Schedule II controlled substances are
23            routinely prescribed by advanced practice
24            registered nurses in their area of certification;
25            the privileging documents must identify the
26            specific Schedule II controlled substances by

 

 

HB4637- 82 -LRB103 35424 SPS 65490 b

1            either brand name or generic name; privileges to
2            prescribe or dispense Schedule II controlled
3            substances to be delivered by injection or other
4            route of administration may not be granted;
5                (ii) any privileges must be controlled
6            substances limited to the practice of the advanced
7            practice registered nurse;
8                (iii) any prescription must be limited to no
9            more than a 30-day supply;
10                (iv) the advanced practice registered nurse
11            must discuss the condition of any patients for
12            whom a controlled substance is prescribed monthly
13            with the appropriate physician committee of the
14            hospital affiliate or its physician designee; and
15                (v) the advanced practice registered nurse
16            must meet the education requirements of this
17            Section;
18        (3) with respect to animal euthanasia agencies, the
19    euthanasia agency has obtained a license from the
20    Department of Financial and Professional Regulation and
21    obtained a registration number from the Department; or
22        (4) with respect to prescribing psychologists, the
23    prescribing psychologist has been delegated authority to
24    prescribe any nonnarcotic Schedule III through V
25    controlled substances by a collaborating physician
26    licensed to practice medicine in all its branches in

 

 

HB4637- 83 -LRB103 35424 SPS 65490 b

1    accordance with Section 4.3 of the Clinical Psychologist
2    Licensing Act, and the prescribing psychologist has
3    completed the appropriate application forms and has paid
4    the required fees as set by rule.
5    (b) The mid-level practitioner shall only be licensed to
6prescribe those schedules of controlled substances for which a
7licensed physician has delegated prescriptive authority,
8except that an animal euthanasia agency does not have any
9prescriptive authority and a physician assistant shall have
10prescriptive authority in accordance with the Physician
11Assistant Practice Act of 1987 without delegation by a
12physician. An A physician assistant and an advanced practice
13registered nurse is are prohibited from prescribing
14medications and controlled substances not set forth in the
15required written delegation of authority or as authorized by
16their practice Act.
17    (c) Upon completion of all registration requirements,
18physician assistants, advanced practice registered nurses, and
19animal euthanasia agencies may be issued a mid-level
20practitioner controlled substances license for Illinois.
21    (d) A collaborating physician may, but is not required to,
22delegate prescriptive authority to an advanced practice
23registered nurse as part of a written collaborative agreement,
24and the delegation of prescriptive authority shall conform to
25the requirements of Section 65-40 of the Nurse Practice Act.
26    (e) (Blank). A collaborating physician may, but is not

 

 

HB4637- 84 -LRB103 35424 SPS 65490 b

1required to, delegate prescriptive authority to a physician
2assistant as part of a written collaborative agreement, and
3the delegation of prescriptive authority shall conform to the
4requirements of Section 7.5 of the Physician Assistant
5Practice Act of 1987.
6    (f) Nothing in this Section shall be construed to prohibit
7generic substitution.
8(Source: P.A. 99-173, eff. 7-29-15; 100-453, eff. 8-25-17;
9100-513, eff. 1-1-18; 100-863, eff. 8-14-18.)
 
10    Section 95. No acceleration or delay. Where this Act makes
11changes in a statute that is represented in this Act by text
12that is not yet or no longer in effect (for example, a Section
13represented by multiple versions), the use of that text does
14not accelerate or delay the taking effect of (i) the changes
15made by this Act or (ii) provisions derived from any other
16Public Act.